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ABSTRACT

Three biologically-active aminothiols cysteamine (CA), DL-cysteine (CYSH)
and DL-homocysteine, were studied in this thesis. These aminothiols react with
nitrous acid (HNO2), prepared in situ, to produce S-nitrosothiols (RSNOs): Snitrosocyteamine (CANO), S-nitrosocysteine (CYSNO) and S-nitrosohomocysteine
(HCYSNO). They also react with S-nitrosoglutathione (GSNO) and S-nitroso-Nacetylpenicillamine (SNAP) through a transnitrosation reaction to produce their
corresponding RSNOs. A detailed kinetics and mechanistic study on the formation of
these RSNOs and their subsequent decomposition to release nitric oxide (NO) were
studied.
For all three aminothiols the stoichiometry of their reaction with nitrous acid is
strictly 1:1 with the formation of one mole of RSNO from one mole of HNO2. In all
cases, the nitrosation reaction is first order in nitrous acid, thus implicating it as a
nitrosating agent in mildly acidic pH conditions. Acid catalyzes nitrosation after
nitrous acid has saturated, implicating another nitrosating agent, the nitrosonium
cation, NO+ ( which is produced from the protonation of nitrous acid) as a contributing
nitrosating species in highly acidic environments. The acid catalysis at constant
nitrous acid concentrations suggests that the nitrosonium cation nitrosates at a much
higher rate than nitrous acid. Nitric oxide itself was not detected as a nitrosant.
Bimolecular rate constants for the nitrosation of CA, CYSH and HCYSH were
deduced to be 17.9, 6.4, 0.09 M-1 s-1 for the nitrosation by nitrous acid and 8.25 x
i

1010, 2.89 x 1010 and 6.57 x 1010 M-1 s-1 for the nitrosation by nitrosonium cation
respectively. A linear correlation was obtained between the rate constants and the pKa
of the sulfur center of the aminothiols for nitrosation by NO+.
The stabilities of the three RSNOs were found to be affected by metal ions.
They were unstable in the presence of metal ions, with half-lives of few seconds.
However, in the presence of metal ion chelators, they were found to be relatively
stable with half-lives of 10, 30 and 198 hours for CYSNO, CANO and HCYSNO
respectively. The relative stability of HCYSNO may be an advantage in the prevention
of its metabolic conversion to homocysteine thiolactone, the major culprit in HCYSH
pathogenesis. This dissertation has thus revealed new potential therapeutic way for the
modulation of HCYSH related cardiovascular diseases.
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CHAPTER 1
INTRODUCTION
1.1

History of Nitric Oxide
Nitric oxide is a paramagnetic molecule which exists as a radical in its ground

state. As a free radical, nitric oxide (·N=O, abbreviated as NO) has interesting
chemistry and has been the focus of many research laboratories in recent years;
probably due to the realization that it could be synthesized by mammalian cells and
act both as a physiological messenger and as a cytotoxic agent.1 Although it was
discovered by Joseph Priestley more than two centuries ago when he reacted nitric
acid with metallic copper (R1.1), little was known about NO until its real biological
importance was announced to the world in 1987.2-6

3Cu + 8HNO3 → 2NO + 3Cu(NO3)2 + 4H2O

R1.1

Since then, more than 20,000 articles have been published on the physiological roles
of this small but highly important molecule. Nitric oxide is known to inhibit
aggregation of platelets and their adhesion to vascular walls7 and is also involved in
host defense by killing foreign invaders in the immune response.8 It acts as a
messenger molecule; effecting muscle relaxation not only in the vasculature, but also
in the gastrointestinal tract.9 It is able to function as a muscle relaxant because of its
ability to increase guanosine 3',5'-cyclic monophosphate (cGMP) in smooth muscle
tissue.10,11 NO has also been shown to acts as a carcinogen,12 a neurotransmitter in the
1

brain and peripheral nervous system13 and is involved in the regulation of gene
expression and modification of sexual and aggressive behavior.14 The role of NO as
an important biochemical mediator of penile erections14 stimulated a pharmaceutical
company (Pfizer) in 1998 to start the production of Viagra, a popular drug whose
mechanism of action is based on the nitric oxide-guanosine 3',5'-cyclic
monophosphate (NO-cGMP) system, which revolutionized the management of erectile
dysfunction.15 Also, a decrease in NO bioavailability has been implicated as a major
factor responsible for so many diseases such as atherosclerosis, diabetes, hypertension,
inflammation, migraine, meningitis, stroke, sickle cell disease and septic shock.15-19
In recognition of the many amazing physiological roles of nitric oxide and the
rate at which the attention of many scientists shifted to its research, the popular
journal, Science, proclaimed nitric oxide as the molecule of the year in 1992.20 In
1998, three scientists were honored with the Nobel Prizes for their discovery of nitric
oxide as a signaling molecule in the cardiovascular system.21 They are Robert
Furchgott of the State University of New York, Louis Ignarro of the University of
California at Los Angeles, and Ferid Murad at the University of Texas Medical
School.21 These scientists were able to establish that the endothelium-derived relaxing
factor (EDRF) is NO.2,4,22,23 The following year, Salvador Moncada, of the University
College, London, who was generally believed to have contributed immensely to the
field of nitric oxide research, was recognized as the most cited United Kingdom
biomedical scientist of that decade.15

2

Nitric oxide is relatively unstable in biological systems due to its reaction with
oxygen (O2), superoxide anion (O2˙¯ ) and haem proteins.24,25 Nitrite (NO2-) is the
major end-product of its reaction with oxygen (R1.2) and nitrite can also release NO
on acidification.26,27 Nitrites and even nitrates have been used for ages in the
preservation of meat.1 They have the advantages of killing the bacterium responsible
for botulism and deepening the red color of meat.

4NO + O2 + 2H2O → 4NO2- + H+

R1.2

1.2 Synthesis of Nitric Oxide in the Physiological Environment
It is now a well established fact that nitric oxide can be synthesis in-vivo via
the oxidation of L-arginine to L-citrulline by the three isoforms of the enzyme, nitric
oxide synthase (NOS).1,26,28 A clear understanding of the biosynthetic pathway of this
inorganic free radical is very important, as it will enable us to decipher its numerous
physiological roles.
The three major isoforms of nitric oxide synthase that have been identified,
characterized, purified and cloned are neuronal NOS (nNOS or NOS-I), inducible
NOS (iNOS or NOS-II) and endothelia NOS (eNOS or NOS-III).29-34 The location,
sources and activation of these isoforms are outlined in Table 1.1. The first of these
NOS to be identified and described was neuronal NOS. It was identified from rat
cerebella and was fully characterized in 1989.35 Apart from NOS, co-factors/coenzymes that play significant roles in nitric oxide synthesis are molecular oxygen, the
3

reduced form of nicotinamide adenine dinucleotide phosphate (NADPH),
tetrahydrobiopterin (BH4), calmodulin, flavin adenine dinucleotide (FAD) and flavin
mononucleotide (FMN).26,29,30,36

Table 1.1: Description of the nitric oxide synthase isoforms

Isoform
nNOs
(NOS I)

iNOs
(NOS II)

eNOs
(NOS III)

Molecular
Weight
kDa
161

131

133

Intracellular
Location
Membrane
associated

Cytosolic

Membrane
(inactive)
Cytosolic
(active)

Human Cellular
Sources
Neurons,
adrenal
medullary
Astrocytes
Macrophages,
monocytes,
leukocytes,

Endothelium,
platelets,
smooth muscle

Presence

Constitutive

Inducibe

Constitutive

Activation
Ca2+ increase
leading to
calmodulin binding
Transcriptional
Induction,
Ca2+ independent,
calmodulin
always bound
Ca2+ increase
leading to
calmodulin binding

The synthesis of nitric oxide as presented in Scheme 1.1 consists of a two-step
process.36,37 The first step involves a two-electron NOS oxidation of the amino acid,
L-arginine in the presense of molecular oxygen, NADPH and BH4 to an intermediate
species, N-hydroxy-L-arginine. The second step corresponds to a three-electron NOS
oxidation of N-hydroxy-L-arginine to form L-citrulline and nitric oxide. The final
organic product of these reactions, L-citrulline can be converted back to L-arginine as
part of the urea cycle. This recycling takes place via a reaction of L-citrulline,
adenosine triphosphate (ATP) and aspartate to form L-arginine and fumarate through
4

the intermediate L-arginosuccinate. It has been shown, through isotopic labeling of the
terminal guanidine nitrogen atoms and molecular oxygen atoms, that the nitrogen
atom as well as the oxygen atom in the synthesized nitric oxide was derived from
these labelled positions respectively.26

R

R

R
O2

HN

NOS
NH2+

H2O

O2
NOS

HN
NOH

NADPH NADP+

H2N

HN

0.5 mol 0.5 mol
NADPH NADP+

H2 N

L-Arginine

H2O

N-Hydroxy-L-Arginine

O + NO
H2N
L-Citrulline

R
NH
H2N

O

HO
O

ATP

AMP

N
O

O
OH
O

-

O
O

-

L-arginosuccinate

-

OH
O
NH2

O

Aspartate

Fumarate
O
where R is HO
NH2

Scheme 1.1:

Pathway for the biological production of nitric oxide (NO).
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1.3

Peroxynitrite Formation: The Toxic Metabolite of Nitric Oxide
The toxicity effects observed with nitric oxide has been attributed to its

diffusion-limited reaction with superoxide anion (O2˙¯) to produce the powerful and
deadly oxidant, peroxynitrite ion (ONOO¯).38,39 Superoxide anion is produced as one
of the intermediates in the reduction of molecular oxygen to water (R1.3 – R1.6).

O2 + e- → O2·-

superoxide anion

R1.3

O2·- + e- + 2H+ → H2O2

hydrogen peroxide

R1.4

H2O2 + e- → OH- + ·OH

hydroxyl radical

R1.5

·OH + e- + H+ → H2O

R1.6

This reactive oxygen species, O2˙¯, could be scavenged by superoxide dismutase
(SOD) and thereby protect nitric oxide from forming peroxynitrite. Thus, there is
competition between nitric oxide and superoxide dismutase for superoxide anion
(Scheme 1.2).40

Scheme 1.2: Reactions of superoxide anion.
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Nitric oxide has been found to be the only biological species that can be produced in
high enough concentrations (micro molar) to out-compete superoxide dismutase for
superoxide anion.41 Reaction of O2˙¯ and NO occurs at such a high rate (6.7 x 109 M1 -1

s ) that nearly every collision results in irreversible formation of ONOO-.41,42 The

concentration of NO, like many free radicals, determines its roles (beneficial or toxic)
in the physiological environment. It is known to perform most of its beneficial roles,
such as vasorelaxation, at low concentrations on the order of 5 – 10 nM because at
these concentration ranges it cannot effectively compete with superoxide dismutase
whose concentrations are approximately on the order of 4 -10 µM.42 It plays a toxic
role when its concentration rises to micro molar levels. There is need, therefore, for
processes that can reduce its concentrations to harmless levels in the physiological
environment. These processes include its reactions with red blood cells
(hemoglobin),43,44 and physiological thiols.26,45,45,46 NO reacts with oxyhemoglobin
and deoxyhemoglobin to produce nitrate plus methemoglobin and Snitrosohemoglobin (SNOHb) respectively.43,47,48 Its reaction with thiols produces Snitrosothiols. Formation of S-nitrosohemoglobin is believed to occur via
transnitrosation involving a direct transfer of NO+ from S-nitrosothiols to
deoxyhemoglobin.26,43,48-50 Thus, hemoglobin can deliver NO to where it is needed
for various physiological functions and in a way remove excess NO which may be
responsible for the pathogenesis of many diseases such as Alzheimer’s disease and
Parkinson’s disease.51 It is reasonable to assume that reversible incorporation of nitric
oxide into compounds that can transport it from donor or site of production to target
7

cells can prevent or diminish nitric oxide toxicity. This further stresses the
physiological importance of S-nitrosothiols, which can protect nitric oxide against
oxidation and releases it during contact with target cells.

1.4

Biological Thiols

Thiols are organosulfur compounds with sulfhydryl functional group (-SH). A good
number of them are relevant in the physiological environment, and the aim of this
thesis is to elucidate the mechanistic basis for the activities of some of these biological
thiols with respect to their reaction with nitric oxide. The most relevant thiols in
biological chemistry are cysteine, homocysteine and glutathione. Glutathione is the
most abundant low-molecular-mass non-protein thiol in mammals, with an adult
human having about 30 g glutathione widely distributed in most tissues.52,53 The levels
in the kidney and liver, however, are significantly higher.54 In general, thiols are
readily nitrosated in the presence of reactive nitrogen species including nitric oxide to
form S-nitrosothiols.
Thiols are highly nucleophilic with a relatively electron-rich sulfur center. This
property is fundamental to the critical role of thiols in protecting cells against
oxidative and nitrosative damage as well as in DNA repair mechanisms (R1.8 –
R1.12) and detoxification of even ordinary drugs such as in acetaminophen
poisoning.54-57

DNA·+ + RSH → DNA + RS· + H+

R1.7
8

Table 1.2: Therapeutic Indications of some selected thiols
Organosulfur
Compound
Cysteine

Structure

H2N

Therapeutic Indications

H

O

C

C

Protection of cells from free radical
damage.58,59

OH

Detoxification of chemicals and heavy
metals.60

CH2
SH

O
C

H

H

O

N

C

C

OH

H3C

Treatment of HIV infection63,64

CH2

N-

SH

To increase intracellular cysteine and
glutathione levels.61

acetylcysteine

H

Cysteamine

H2N

Prevention of hypothyroidism and
enhancement of growth in patients
with nephropathic cystinosis.65-67

H

C

To increase antioxidant glutathione59
Treatment of acetaminophen over
dosage.61,62

CH2

Used in topical eye drops to dissolve
corneal cystine crystals.68

SH
H

H2N

Taurine

Methionine

H 2N

C

Treatment of congestive heart
failure.69,70

H

CH2

Controlling of diabetes.71,72

SO3H

Inhibition of platelet aggregation.71,73

H

O

C

C

Ethanol detoxification.76

CH2
CH2
S

OH

Treatment of acetaminophen
poisoning.74,75

CH3

Prevention of fatty liver via
transmethylation to form choline (lack
of choline contributes to liver cirrhosis
and impaired liver function).77,78
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DNA·+ + RS- → DNA + RS·

R1.8

RSSR·- + H+

R.19

RS· + RSH

RSSR·- + DNA·+ → DNA + RSSR

R1.10

Conjugation of xenobiotics with nucleophilic thiols is a major pathway by which the
body eliminates drugs.57 A few selected examples of thiols that are being used in
medicine as therapy to cure some specific human diseases are presented in Table 1.2.
A thorough examination of thiols shows that the most important parameter
associated with their physiological role is the nature of the reactivity of the sulfurcenter.79 In this study, this thesis will therefore try to show that the reactivity at the Scenter is extremely useful in predicting the effect of ingestion and/or inhalation of
sulfur-based compounds, either intentionally as therapeutic drugs or unintentionally as
xenobiotics such as second hand cigarette smoke.

1.5

S-Nitrosothiols
Nitric oxide should, just like most common radicals such as hydroxyl radical

and superoxide anion (O2˙¯ ), not be able to exist freely in the physiological
environments. It is a short-lived free radical that reacts once it forms (half-life of 0.1 6 s).80 For NO to fully perform its physiological roles, therefore, there is a need for
endogenous carriers that can easily release it whenever it is needed. Metal- and thiolcontaining proteins and low molecular weight thiols have been found to be the main
target sites for nitric oxide within the cell.26 Nitric oxide readily reacts with
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physiological thiols to produce S-nitrosothiols. Examples of some synthetic and
naturally occurring S-nitrosothiols are listed in Figure 1.1.

O

O
SNO

SNO
OH

OH
NH

O
OH

NH2
NH

NH

O

O

O

S-nitroso-N-acetyl-D,L-penicillamine

S-nitroso-L-glutathione

CH2OH
OH

O

SNO

O

O

OH
SNO
NH

OH
OH

S-nitroso-N-acetyl-L-cysteine

S-nitroso-B,D-glucose

SNO
SNO

N

OH
NH2
O
O

O
OH

S-nitrosohomocysteine

S-nitrosocaptopril

SNO
SNO
SNO
NH2

OH
O
OH

NH2

S-nitroso-L-cysteine

S-nitrosocysteamine

O

S-nitroso-3-mercapto-propanoic acid

Figure 1.1: Examples of some synthetic and naturally occurring S-nitrosothiols.
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S-Nitrosothiols, with the general structure, RSNO (where R is mainly an
organic group), are an emerging class of both endogenous and exogenous nitric oxide
donors. The existence of natural thiol-containing proteins and peptides such as
cysteine,81,82 glutathione83 and albumin,83-85 and their nitrosation led to the general
belief that S-nitrosothiols are endogenous reservoirs, transport and delivery carriers for
nitric oxide. It has been claimed that the bulk of nitric oxide circulates in blood plasma
as S-nitroso form of serum albumin (SASNO), the S-nitroso derivative of serum
albumin which is believed to be the most abundant S-nitrosated protein ( ~ 7.0 µM).86
The concentration of circulating nitrosothiols, however, may bear no relationship to
intracellular concentrations that are likely to contribute more to physiological
reactions.46,87-89 There is also evidence that seems to suggest that endogenously
produced RSNOs are active intermediates responsible for the pharmacological effects
of nitroglycerin and other nitro-vasodilators that release NO in the vasculature and
platelets.90-92

1.5.1 Biological and Physiological Functions of RSNOs
RSNOs have been shown to perform the same physiological role as nitric
oxide itself.49,93-95 For example, just like nitric oxide, N-acetyl-S-nitrosopenicillamine
is known to inhibit platelet aggregation and can also act as a protective agent against
intestinal damage induced by endotoxins.90,96 Platelets and neutrophils are both
involved in the inflammatory process and their interaction might be of importance in
vascular injury. They have been found to inhibit the adhesion of neutrophils to both
12

platelets and endothelium through regulation of adhesion molecule expression.96 It has
been reported that S-nitrosoglutathione (GSNO) and oxidized glutathione (GSSG) can
stimulate L-arginine transport in human platelets, providing another potential
mechanism by which RSNO could affect platelet aggregation.97
RSNOs are responsible for vasodilation of arteries and veins and Snitrosohemoglobin has been implicated in regulation of blood flow via the release on
NO. Once formed, NO diffuses to the underlying smooth muscle cells, where it binds
rapidly to the heme group of the enzyme guanylate cyclase which in turn stimulates
the production of cyclic guanosine monophosphate (cGMP). This sets up a sequence
of events eventually resulting in relaxation of the vessel.91,98,99 This mechanism of
operation is supported by claims that even low molecular weight RSNOs such as Snitrosocysteine (CySNO) are unlikely to permeate cell membranes readily because
they exhibit negligible distribution from aqueous solution to non-polar phases at
physiological pH.91 Cell-surface electron transport chains make this action possible
through a one-electron reduction of RSNO to release NO to other thiol-containing
species on the cell surface through transnitrosation and subsequently regeneration of
the parent thiol.
RSNOs have been synthesized and administered clinically.100 For example,
GSNO is already being administered in clinical trials (at lower concentrations than
those required for vasodilation) for use during coronary angioplastic operations where
it can be used to reduce clotting.88 GSNO has also been successful in treating the
HELLP (hemolysis, elevated liver enzymes and low platelets) syndrome in pregnant
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women.87 The hypertension associated with this syndrome is believed to be associated
with a deficiency in NO production. Clinical trials with other RSNOs are limited due
to the rarity of the disorder. Irradiation of GSNO with visible light in the presence of
leukemia cells has shown that it has cytotoxic effects to these cells thus phototherapy
with GSNO is a potential treatment for leukemia.87
RSNOs have also been shown to improve end-organ recovery in models of
ischemia/reperfusion injury in the heart and liver.87 Ischemia is a condition where the
oxygen-rich blood-flow to a part of the body is restricted, and the surge of blood into
tissues when this restriction is removed is what is termed reperfusion. Reperfusion of
ischemic tissue leads to inflammatory responses and endothelial cell dysfunction
through a sudden overproduction of reactive oxygen species such as hydrogen
peroxide.98 Cardiac ischemia occurs when an artery becomes narrowed or blocked for
a short time, preventing oxygen-rich blood from reaching the heart. If ischemia is
severe or lasts too long, it can cause a heart attack and can lead to heart tissue death.
Hemoglobin has also been shown to exist in the S-nitrosated form and it is believed
that S-nitrosation occurs either in the lungs from reaction with NO produced there or
via transnitrosation46,88 (e.g. with GSNO). Due to the allosteric changes which
accompany the oxygenation of hemoglobin, transnitrosation is very likely. The
nitrosyl group in S-nitrosohemoglobin (HbSNO) may be reduced to NO under certain
conditions, to induce relaxation of pre-capillary vessels and to inhibit platelet
aggregation. Existing evidence suggests that S-nitrosation favors the formation of a
high oxygen affinity state of hemoglobin, and therefore transnitrosation from HbSNO
14

to GSH is thermodynamically favored in the deoxygenated state which allows for
GSNO formation in low-oxygen conditions.97,99,101 Transnitrosation between GSNO
and the high molecular weight anion exchange protein then transduces the NO signal
out of the red blood cell.
Like NO, RSNOs appear to have a role to play in host defense, affecting both
viruses and bacteria. Levels of RSNOs in respiratory pathways are affected by
diseases such as asthma and pneumonia and it is believed that RSNOs act as
bronchodilators and relax bronchial smooth muscle and thus should have a role to play
in the treatment of these diseases.87 RSNOs, together with NO, have also been
implicated in suppression of HIV-1 replication by S-nitrosylation of the cysteine
residues in the HIV-1 protease.87 Nitrosylation of another protease enzyme in the
human rhinovirus that causes the common cold is also believed to be a possible way of
using RSNOs to cure colds. Thus, RSNOs have a potential role in the treatment of
asthma and as agents for treatment of infectious diseases ranging from the common
cold to AIDS.
RSNOs have also been implicated in regulation of ion channels, and among
several NO-sensitive channels, cyclic nucleotide-gated channel (CNG) is the only one
that has been shown to directly open due to S-nitrosylation.102-104 Many such channels
have oxidizable thiol groups that may play a role in the control of channel activity in
vivo and their presence could suggest that regulation by S-nitrosothiols may occur.96,97

15

1.5.2

Formation and Decomposition of S-Nitrosothiols
It has been suggested that the formation and degradation of S-nitrothiols is a

dynamic process that is highly influenced by the existing redox environments.105
Therefore, in order to understand mechanism of formation and degradation of Snitrosothiols, it is important to examine the basic chemistry of nitric oxide with respect
to its reaction with molecular oxygen, the most abundant oxidant in the physiological
environment. Reaction of nitric oxide with oxygen produces nitrites (R1.2) via a
cascade of intermediate reactions (R1.11 – R1.15)26,27 These intermediate reactions
produce reactive nitrogen species (RNS), which include NO2, NO2-, N2O4 and N2O3.26
RNS play significant roles in the formation of S-nitrosothiols.

2·NO + O2 → 2NO2

R1.11

·NO + NO2 → N2O3

R1.12

NO2 + NO2 → N2O4

R1.13

N2O3 + H2O → 2NO2- + 2H+

R1.14

N2O4 + H2O → 2NO2- + NO3- + 2H+

R1.15

1.5.2.1 Endogenous Formation of S-Nitrosothiols
It is well established that S-nitrosothiols are readily formed in the
physiological environment via the interaction of NO-derived metabolites with
thiols.106-108 While there are thousands of articles and reviews on the importance of Snitrosothiols as a signaling paradigm, their in vivo mechanisms of formation, which
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are vital prerequisites for the proper understanding of their physiological roles, remain
a topic of debate.
S-nitrosothiols can be formed from the reaction of nitrous acid (HNO2) with
thiols. Nitrous acid is a weak acid with pKa value of 3.15 at 25 ºC.26 It is easily
formed in acidic aqueous solution of nitrite ion. In excess nitrite, N2O3 is formed
through a condensation reaction of two molecules of nitrous acid (R1.16) and in
excess acid, HNO2 is protonated to form H2NO2+ (R1.17), which can decompose to
release nitrosonium ion, NO+ (R1.18).109,110

2HNO2

N2O3 + H2O

HNO2 + H3O+
H2NO2+

H2NO2+ + H2O

NO+ + H2O

R1.16
R1.17
R1.18

HNO2, N2O3, H2NO2+ and NO+ readily react with thiols to form S-nitrosothiols (R1.19
– R1.22)
HNO2 + RSH → RSNO + H2O

R1.19

N2O3 + RSH → RSNO + NO2- + H+

R1.20

H2NO2+ + RSH → RSNO + H2O + H+

R1.21

NO+ + RSH → RSNO + H+

R1.22

Reactions between thiyl radicals (RS·) and ·NO has also been shown to produce Snitrosothiols in the physiological environment (R1.23).109 In addition to these
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mechanisms, S-nitrosation can also occur by reaction of a thiol with an already formed
S-nitrosothiol. This process is called transnitrosation (R1.24), which often results in
the modification of physiological thiols.111

RS· + ·NO → RSNO

R1.23

RSNO + R'SH → RSH + R'SNO

R1.24

The biological importance of reaction R1.24 is that low molecular weight Snitrosothiols are able to modify protein cysteinyl residues and also convert protein
S-nitrosothiols back to the original protein thiols.112,113
Experimentally, synthesis of S-nitrosothiols using acidified nitrite is only
suitable for low molecular weight thiols such as glutathione and cysteine, but is
unsuitable for proteins because of acid denaturation. Non-thiol functional groups in
proteins such as amines, alcohols and aromatics are also susceptible to modification by
acidified nitrite.97 Spontaneous transfer of the nitroso group from a low molecular
weight RSNO such as CySNO to a protein thiol is the most often used method for
synthesis of protein S-nitrosothiols.114 When transnitrosation occurs from a stable
thiol to an unstable one, release of nitric oxide is facilitated, more so in the presence of
metal ions.115 Because of the vast excess of GSH over every other thiol in the
cytoplasm, it is likely that the transfer of NO+ will be effectively unidirectional from
other S-nitrosothiols to glutathione.46,116-118 Ascorbate has also been shown to promote
NO formation in blood plasma based on this reaction. Such transnitrosation reactions
18

provide possible pathways for the nitrosonium functional group to cross biological
membranes and enter cells.117

1.5.1.2 Stability and decomposition of S-nitrosothiol
S-nitrosothiols, RSNOs, differ greatly in their stabilities, and most of them
have never been isolated in solid form. Their degradation to release NO is believed to
occur both enzymatically and nonenzymatically (Scheme 1.3).27 Apart from NO, the
disulfide of the corresponding parent thiol is also produced as one of the major
products of RSNO decomposition (R1.25).

2RSNO → RSSR + 2NO

R1.25

While nonenzymatic decomposition is known to be influenced by factors such as heat,
UV light, certain metal ions, superoxide anion, ascorbic acid and thiols,119-122
enzymatic decomposition can be influenced by the enzymes glutathione peroxidase,123
γ-glutamyl transpeptidase124 and xanthine oxidase.125 Seleno compounds mediated
non-enzymatic degradation of RSNO is another important pathway that easily occurs
in physiological environments.96 Selenium is an essential mineral in mammals whose
deficiency is closely associated with many heart diseases such as myocardial necrosis
and atherosclerosis.96 People with these disorders are given diets which have a higher
amount of selenium thus making the selenium catalyzed decomposition important. It
has been shown that glutathione peroxidase, an essential selenium containing
19

antioxidant enzyme, potentiated the inhibition of platelet function by RSNOs and also
catalyzed the metabolism of GSNO to liberate NO in the presence of peroxide.116
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Scheme 1.3: Mechanism of S-nitrosothiol decomposition

Homolytic cleavage
RS

NO

NO + RS

R1.26
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Heterolytic cleavage
RS+ + NORS

NO

R1.27
RS- + NO+

The mechanism of decomposition generally involves both homolytic (R1.26)
and heterolytic (R1.27) cleavage of the sulfur-nitrogen bond of the RSNO. Homolysis
of the S-N bond occurs both thermally and photochemically, but, generally, these
processes are very slow at room temperatures and in the absence of radiation of the
appropriate wavelength.

Many of the physiological roles of RSNO have been attributed to homolytic
cleavage of the S-NO bond, with estimated bond dissociation energy of between 22
and 32 kcal/mol.126 Decomposition via transnitrosation has been shown to occur by a
heterolytic cleavage in which NO+ group is transferred to another thiol.46 This may
eventually result in the release of NO if the resultant compound is more susceptible to
decomposition than the parent S-nitrosothiol compound.46

Catalytic effect of copper on the decomposition of S-nitrosothiols: Since human
body contains 0.1 g copper per 75 kg body weight widely distributed in the blood,
bone, and muscle, copper ion-catalyzed decomposition of RSNO has drawn the most
attention.96,118 Presence of trace amounts of Cu(II) or Cu(I) can efficiently catalyze
21

RSNOs to disulfide and nitric oxide. The characterization of the S-N bond is crucial in
determining the stability of RSNOs. Unfortunately, very little work has been done in
this area. The little crystallographic data available on isolable RSNOs indicate that the
S-N bond is weak, sterically unhindered, and elongated at between 0.17 – 0.189 nm127
and exists as either the cis (syn) or trans (anti) conformers (R1.28).26 These
conformers are nearly isoenergetic but separated by a relatively high activation barrier
of ~ 11 kcal mol-1.128

R
S
R

N

S
O

R1.28

N
O
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CHAPTER 2
INSTRUMENTATION, MATERIALS AND METHODS
2.1

INTRODUCTION
The study of rates of chemical reactions is unique and quite different from

other disciplines of science in that it differs from case to case depending on the
particular combination of the relevant reactants. The uniqueness becomes well
pronounced when dealing with non-linear reactions such as those observed with sulfur
and its compounds.129-131 Reaction dynamical studies involving sulfur and its
compounds have been shown to involve intermediate reactions as well as other nonlinear kinetics features such as autocatalysis, autoinhibition, free radical mechanisms,
polymerizations, and a wide range of pH values over which such reactions are
viable.132-135 For example, oxidation of cysteine, H3N+CH(COO-)CH2SH, an essential
amino acid, by acidic bromate was shown to produce cysteic acid,
H3N+CH(COO-)CH2SO3H, as the most stable final product via cysteine sulfenic acid
(H3N+CH(COO-)CH2SOH) and cysteine sulfinic acid (H3N+CH(COO-)CH2SO2H)
intermediates.136 When the same sulfur compound (cysteine) was reacted with nitrous
acid S-nitrosocysteine (H3N+CH(COO-)CH2SNO) was produced, which subsequently
decomposed to form cystine, a disulfide of cysteine as the most stable final
product.117,137 A better understanding of this kind of complex reaction behavior can
only be possible after the kinetics of the individual elementary steps have been studied
and the mechanisms of the relevant reactions have been characterized. This requires
accurate determination of stoichiometry, identification of intermediate(s) and the final
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reaction products. There is need, also, for the measurement of as many properties of
the system as possible, such as concentration, pH and rate dependence. All these
require a careful choice of analytical techniques and specialized instrumentation,
guided by the speed of reaction under consideration.
The kinetics of a typical reaction can be monitored by among others, the
following analytical techniques: nuclear magnetic resonance, electron paramagnetic
resonance, ultraviolet and visible spectroscopy, chemical trapping, gas
chromatography, and mass spectroscopy. For example, conventional methods like
UV/Vis spectrophotometery are only adequate for monitoring kinetics of slow
reactions with half-lives of at least several minutes. A fast reaction can be followed by
stopped-flow techniques, which involve the fast flowing together of separate solutions
of the reactants. This rapid mixing is usually coupled to a rapid-response method for
monitoring the progress of reaction with a half-life of as low as 10-3 s.138

2.2

INSTRUMENTATION

2.2.1

Conventional UV/Vis Spectrophotometry
Reactions with half-lives of at least several minutes were followed on a

conventional Perkin-Elmer UV-VIS Lambda spectrophotometer featuring a double
beam, all-reflecting system within the range of 190 nm to 1100 nm. For this
instrument, the visible region uses a halogen lamp and the UV region uses deuterium
lamp.139
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The spectrophotometer is interfaced to a Pentium III computer and uses the
Perkin-Elmer UV WinLab software139 for data acquisition, storage and analyses. Path
length of the cuvette is 1 cm and a constant temperature of 25 oC is maintained during
the duration of data acquisition by using a Neslab RTE-101 thermostated water bath.
2.2.2

Stopped-flow Spectrophotometry
Most of the processes in this study are too fast to be monitored by the

conventional UV/Vis spectrophotometric techniques. Some of the reactions are
completed within 1.0 s or less. For example, some reactions of cysteamine with
nitrous acid started in less than 0.5 s and completed within 10 s. There is a need for an
instrument that can combine rapid mixing with a rapid analytical response to monitor
this type of reaction. One of such instruments that is capable of doing this is a stoppedflow spectrophotometer. A Hi-Tech Scientific SF61-DX2 double mixing stopped-flow
spectrophotometer (Scheme 2.1) was used for all rapid kinetics reported for these
studies. It consist of sample handling unit (Scheme 2.2), control unit, stepper support
unit and data acquisition system. Small volumes of solutions are driven from high
performance syringes through high efficiency mixer(s). The sample handling unit
facilitates both the single mixing of two reagents, using only one of the drives, or
double mixing of three reactants by a push-push mode of operation. Double mixing
mode enables transient species formed by mixing reactants in A and B to be
subsequently mixed with a third reactant, C, after a delay period. Reactant reservoir D
is reserved for the buffer and this will push the premixed solutions A and B (from
mixer 1) to a second mixer (mixer 2) where it reacts further with reactant C.
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Figure 2.1: Schematic diagram showing all components of the SF-61DX2 Hi-Tech
KinetAsyst stopped-flow spectrometer.
[Courtesy of Hi-Tech Scientific operator’s Manual]

Figure 2.2: Sample Handling Unit (SHU) flow circuit diagram for the SF-61DX2
Hi-Tech KinetAsyst stopped-flow spectrometer.
[Courtesy of Hi-Tech Scientific operator’s Manual]
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The resultant mixture passes through a measurement flow cell and into a stopping
syringe where the flow is stopped. Just prior to stopping, a steady state flow is
achieved. The solution entering the flow cell is only milliseconds old. The age of this
reaction mixture is also known as the dead time of the stopped-flow system. As the
solution fills the stopping syringe, the plunger hits a block, causing the flow to be
stopped instantaneously and triggering the observation cell optics. Using appropriate
techniques, the kinetics of the reaction can be measured in the cell.
The radiation source is a 12 V, 50 W quartz tungsten halogen lamp. The
instrument can also be operated with a 75 W light noise xenon arc lamp or a 100 W
short arc Mercury lamp as radiation sources. The monochromator used is a CzernyTurner type mounted on a rail. There are two photomultipliers, a PM-60e (an end-on
½ inch Hamamatsu R1463) and a PM-60s (a side-on 1-1/8 inch Hamamatsu R928
HA). The passage of light from the monochromator to the photomultiplier is through a
600-micron pure silica optic fiber. The optical cell is made from fused UV silica. It
measures 10 mm x 1.5 mm x 1.5 mm. The path length can be 10 mm or 1.5 mm
depending on the position of the optic fiber.

2.2.3

High Performance Liquid Chromatography (HPLC)
High Performance Liquid Chromatography (HPLC) is the most versatile and

widely used type of elution chromatography. It is an excellent technique for the
separation and determination of species in a variety of organic, inorganic and
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biological materials. In HPLC, the mobile phase is a liquid solvent containing the
sample as a mixture of solutes.
HPLC analysis in this study was performed on a Shimadzu Prominence HPLC
system controlled by a web browser through a static IP address using the CBM-20A
Prominence BUS Communication Module (Columbia, MD). The system consists of an
LC-20AT Prominence LC (Kyoto, Japan) containing four LC-600 pumps, a DGU20A5 Prominence degasser (Kyoto, Japan) and an SIL-10AD VP auto-injector
(Columbia, MD). Detection was performed using an SPD-M10A Diode Array
Detector (Columbia, MD) and an RF-10A XL fluorescence detector (Columbia, MD).
HPLC grade solvents were filtered on 0.5 µm FHUP (organic) and 0.45 µm HATF
(aqueous) Millipore isopore membrane filters (Bedford, MA) before they could be
passed through the degasser. Injection volumes ranged from 10 µl to 100 µl and
separations were carried out on a 5 µm particle size, 250 x 4.6 mm Supelco Discovery
(Bellefonte, PA) C18 column (reverse phase, 100 Å pore size) at flow rates ranging
from 0.5 ml/min to 1 ml/min. Solvents used were acetonitrile, methanol and water. 1
% trifluoroacetic acid (TFA), 1 % formic acid (FA) and other buffered solvents were
incorporated whenever the need arose and either isocratic or gradient elutions were
utilized. To curb the interaction of the protonated amines on the analytes with the
silanol groups on the stationary phase (which was causing tailing of peaks) the sodium
salt of 1-octanesulfonic acid (0.005 M) was incorporated into the aqueous mobile
phase. This was sufficient to neutralize the protonated amines and produce good
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resolution while eliminating peak tailing. Data were acquired and analyzed using the
EZ-Start 7.3 Chromatography Software for Windows (Columbia, MD).

2.2.4

Mass Spectrometry (MS)
Most of the reactions being studied are new, and this makes product

identification very important. In conjunction with HPLC, mass spectrometry analyses
were used to identify the products of the reactions. The mass spectrometer used is a
Micromass QTOF-II (Waters Corporation, Milford, MA) quadrupole time-of-flight
mass spectrometer (qTOF MS). Analyte ions were generated by positive-mode
electrospray ionization (ESI). Samples were dissolved in 50/50 acetonitrile/water and
pumped through a narrow, stainless steel capillary (75 – 150 µm i.d.) at a flow rate of
between 1 µL/min and 1 mL/min. A voltage of 3 or 4 kV was applied to the tip of the
capillary, which was situated within the ionisation source of the mass spectrometer.
The strong electric field, aided by a co-axially introduced nebulizing gas (nitrogen)
flowing around the outside of the capillary, dispersed the solution emerging from the
tip into an aerosol of highly charged droplets. The source block was maintained at 80
0

C with the desolvation gas (nitrogen) maintained at 150 0C and a flow rate of 400 L/h.

The warm flowing nitrogen assisted in solvent evaporation and helped direct the spray
towards mass spectrometer. The charged sample ions, free from solvent, passed
through a sampling cone orifice into an intermediate vacuum region and from there
through a small aperture into the analyser of the mass spectrometer which was held
under high vacuum. The lens voltages were optimised individually for each sample.
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The settings varied with each set of experiments. Tandem mass spectrometry (MSMS)
data was generated by collision-induced dissociation (CID) with argon. Visualization
and analysis of data was done using the Micromass MassLynx 4.0 software suite for
Windows XP (Waters Corporation, Milford, MA).

2.2.5

Nuclear Magnetic Resonance Spectrometry
Nuclear Magnetic Resonance (NMR) is the study of the properties of

molecules containing magnetic nuclei by applying a magnetic field and observing the
frequency at which they come into resonance with an oscillating electromagnetic
field.140 In this study, Proton NMR (1H NMR) was used. It is an important analytical
tool that can be used to determine the number of distinct types of nuclei as well as
obtain information about the nature of the immediate environment of each type of
hydrogen nuclei in the organic products of the reactions. During oxidation of an
organosulfur compound, the environment around the S-atom changes and the protons
bonded to the adjacent carbon, nitrogen or oxygen atoms also change in terms of
chemical shifts. This change in chemical shifts, together with deshielding effects
make it possible to follow the progress of the oxidation of a sulfur center.
Proton NMR spectra were obtained using a Tecmag-modified Nicolet NM 500
spectrometer. The spectrometer was operated using a low power pre-saturation pulse
at the water resonance position during the 2 s relaxation delay. A total of 8192
complex data points were collected for each spectrum, with a spectral width of ± 3000
Hz in quadrature for 16-128 transients, depending upon individual sample signal-to30

noise. To enhance the signal-to-noise ratio, the data points were typically treated with
an exponential decaying function, leading to a 1 Hz line broadening before zero-filling
twice, prior to applying a Fourier transformation. The data were processed using
Swan-MR software. Spectra were referenced to 0 ppm via internal trimethylsilane
(TMS) or via the water resonance (4.76 ppm at 298 K). Final visualization and
analyses of the 2-D data sets were performed using NMR View or Swan-MR.

2.2.6

Electron Paramagnetic Resonance (EPR) Spectroscopy

EPR was discovered in 1944 by E.K. Zavoisky.141 It is a non-destructive analytical
technique used for studying molecules with one or more unpaired electrons. In EPR
spectroscopy the energy differences, ∆E, due to interaction of unpaired electrons in the
sample with a magnetic field produced by a magnet are studied. Absorption occurs
when ∆E equals the microwave energy, hν. Equation 2.1 and Figure 2.3 describe the
general principle of EPR.

∆E = hν = gβH

2.1

where h is Planck’s constant, ν is microwave frequency, β is Bohr magneton (a
constant related to electron charge and mass), H is magnetic field at which resonance
occurs, g is a spectroscopic factor, which is a characteristic of a given paramagnetic
center. The shape and width of the spectral line as well as the hyperfine (splitting) and
area under absorption curve are other important parameters in EPR spectroscopy.
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Figure 2.3: The general principle of EPR spectroscopy.

The area which is the double integral of the 1st derivation curve is proportional to the
amount of a given paramagnetic center (spin) present in the resonator cavity of the
EPR machine.141
For all EPR studies, a Bruker e-scan EPR spectrometer (X-band) was used for the
detection of radicals and to confirm the release of NO upon the decomposition of
RSNO (equation 2.2). Since direct detection of NO is difficult due to its broad EPR
spectrum,141 EPR spin trapping technique was employed. EPR spin trapping is a
process whereby a short-lived radical like NO is intercepted by a spin trap resulting in
the formation of a radical-spin trap adduct which is stable enough to be detected and
characterized by EPR spectroscopy. The intensity of the EPR signal is proportional to
the amount of adduct formed. NO-specific spin trap, aci-nitroethane, was used for the
detection of NO142. In alkaline environments, nitroethane (CH3CH2NO2) forms aci
anion (equation 2.3) which can effectively scavenge NO to form long-lived NOadduct (equation 2.4).
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RSNO → RSSR + NO

(2.2)

CH3CH2NO2 + OH- → CH3CH=NO2- + H2O

(2.3)

CH3CH=NO2- + NO + OH- → [CH3C(NO)(NO2)]˙2- + H2O

(2.4)

The following settings were used for a typical run: microwave power, 19.91 mW;
modulation amplitude, 1.41 G; receiver gain, 448; time constant, 10.24 ms; sweep
width, 100 G and frequency, 9.78 GHz. All measurements were taken at room
temperature.

2.3

MATERIALS

2.3.1

Sulfur Compounds: All the sulfur compounds (thiols, mostly) used in this

work (Table 2.1) were used without further purification. Choice of these compounds
was based on their known physiological effects.

2.3.2

Ionic Strength: Sodium perchlorate (from Fisher Scientific) was used to

maintain an ionic strength of 1.0 M in all kinetic experiments.

2.3.3

Nitrosating Agent: The nitrosating agent of choice for the investigation of

kinetics and mechanisms of nitrosation of the selected sulfur compounds in this work
is nitrous acid (HNO2), which is generated in situ during the kinetic experiments via a
reaction of sodium nitrite and perchloric acid from Fisher Scientific.
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Table 2.1: Organosulfur Compounds
Chemical Name

Acronym

Source

Cysteamine hydrochloride

CA

Sigma-Aldrich

Cystamine dihydochloride

-

Sigma-Aldich

L-Cysteine

CYSH

Sigma-Aldrich

L-Cystine

CYSSCY

Acros Organics

DL-Homocysteine

HCYSH

Acros Organics

Homocystine

HCYSSHCY

Acros Organics

Glutathione

GSH

Acros Organics

N-acetyl-D-penicillamine

NAP

Sigma-Aldrich

2.4 EXPERIMENTAL TECHNIQUES
2.4.1

Nitrosation Reactions: All nitrosation experiments were carried out at 25.0 ±

0.1 °C and at a constant ionic strength of 1.0 M (NaClO4). The reaction system studied
is essentially the HNO2-organosulfur compound reaction. The progress of this reaction
was monitored spectrophotometrically by following the absorbance of S-nitrosothiols
(RSNOs) at their experimentally determined absorption peaks. Three vessels were
used for the mixing of reactants. Sodium nitrite and sodium perchlorate were mixed in
the first vessel, perchloric acid solutions in the second vessel and Organosulfur
compound in the third vessel. Kinetics measurements were performed on the Hi-Tech
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Scientific double-mixing SF61-DX2 stopped-flow spectrophotometer. Stock solutions
of thiols and nitrite were prepared just before use.

2.4.2

Stoichiometry Determination:

Stoichiometric determinations were

performed by varying NO2- and keeping both thiols and acid constant and testing for
the presence of any remaining NO2- as the nitrous acid (HNO2).143 The presence of
NO2- was quantitatively analyzed (gravimetrically) as the orange chloride salt of pnitroso-N,N-dimethylaniline that was formed when the solution was reacted with N,Ndimethylaniline. Reaction was guaranteed to proceed to completion by maintaining
both acid and nitrite in excess over thiols. Due to the well-known decomposition of
nitrosothiols, product reaction solutions were not allowed to stand for more than an
hour before the addition of N,N-dimethylaniline.144 The salt formed, however, was
allowed to settle for 24 h before being filtered, dried, and weighed.

2.4.3

Test for Adventitious Metal Ion Catalysis: Water used for preparing reagent

solutions was obtained from a Barnstead Sybron Corporation water purification unit
capable of producing both distilled and deionized water (Nanopure). Inductively
coupled plasma mass spectrometry (ICPMS) was utilized to quantify the
concentrations of metal ions in this water. ICPMS analysis showed negligible
concentrations of copper, iron, and silver (less than 0.1 ppb) and approximately 1.5
ppb of cadmium as the metal ion in highest concentrations. Control experiments were
performed in distilled deionized water treated with the chelators EDTA or
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deferroxamine to establish the possible catalytic effects of adventitious metal ions.
The reaction dynamics were indistinguishable from those run in distilled deionised
water.

2.4.4

Computer Simulation: The proposed step-by step mechanisms of the kinetic

reactions in this study were computer simulated to check for plausability. These
simulations are important as they allow detailed models to be developed and tested as
data accumulate. They provide a means of evaluating various hypotheses for further
experimental investigation. These include reaction mechanism, with appropriate rate
constants and a set of parameter values describing the initial conditions which are
similar to those used in the experiment. The models give concentrations of the
chemical variables as a function of time, which can be compared to the experimental
traces. Usually, guessed variables like rate constants are altered until the simulated
traces are comparable to the experimental traces. Those rate constants derived from
literature values are not altered.
Kintecus software developed by James C. Ianni was used for carrying out
simulations in this study.145 It is a reliable compiler used to model the reactions of
chemical, biological, nuclear and atmospheric processes using three input data files: a
reaction spreadsheet, a species description spreadsheet and a parameter description file.
In addition, one can fit/optimize almost any numerical value (rate constants, initial
concentrations, starting temperature, etc.) against an experimental dataset. Normalized
sensitivity coefficients are used in accurate mechanism reduction, determining which
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reactions are the main sources and sinks (network analysis) and also shows which
reactions require accurate rate constants and which ones can have essentially guessed
rate constants. Kintecus software is a user friendly package requiring no programming
or compiling skills by the user.
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CHAPTER 3
KINETICS AND MECHANISMS OF NITROSATION OF CYSTEAMINE
3.0 INTRODUCTION
Cysteamine (2-aminoethanethiol) is an important biological molecule,
consisting of a sulfhydryl group and an amino functional group.

cysteamine

Medically known as Cystagon, it can be used as oral therapy for prevention of
hypothyroidism and enhances growth in patients with nephropathic cystinosis.67,146
This is a lysosomal storage disorder which was long considered primarily a renal
disease, but is now recognized as systemic disorder which eventually affects many
organ systems in children.147 This disorder is characterized by cystine accumulation
within cellular lysosomes, and cysteamine converts this disulfide into cysteine and a
mixed disulfide, cysteamine-cysteine, which can easily be eliminated from the
cystinotic lysosomes, thus effecting depletion of cellular cystine.148 Lysosomes are a
major intracellular site for the degradation of a wide variety of macromolecules
including proteins, nucleic acids, complex carbohydrates, and lipids. Cysteamine and
its disulfide, cystamine, can also be used in topical eye drops to dissolve corneal
cystine crystals.66,68
In addition to protection against radical damage in DNA, cysteamine can also
act as a repair agent for DNA through the formation of the protective RSSR•- which
38

then reacts with the DNA•+ radical ion to regenerate DNA and form cystamine, the
cysteamine disulfide.54-56 The ability of cystamine to reversibly form disulfide links
with the sulfhydryl groups at or near the active sites of enzymes is also important in
regulation of several essential metabolic pathways.149,150
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HO
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Figure 3.1:
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NH
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CH2

SH

Cysteamine

Structure of Coenzyme A showing the cysteamine residue.

Cysteamine is known to be produced in vivo by degradation of coenzyme A,
where it forms its terminal region (Figure 3.1). Coenzyme A is a cofactor in many
enzymatic pathways, which include fatty acid oxidation, heme synthesis, synthesis of
the neurotransmitter acetylcholine and amino acid catabolism.151 Recently, a second
mammalian thiol dioxygenase was discovered to be cysteamine dioxygenase.152 The
first thiol dioxygenase to be discovered was cysteine dioxygenase.152-154 The discovery
of this new enzyme, cysteamine dioxygenase, further implicates cysteamine as being
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as important as cysteine and glutathione in the physiological environment. Thus,
knowledge of the kinetics and mechanisms of the metabolism of cysteamine is
paramount to understanding its physiological importance. Although many studies have
been conducted on metabolism of this thiol and its metabolites with respect to
oxidation by oxyhalogen species,155-157 nothing in-depth has been done on the
elucidation of its mechanism of nitrosation to form S-nitrosocysteamine. In this thesis
results are presented on the kinetics and mechanism of formation and decomposition
of S-nitrosocysteamine.

3.1

RESULTS
The progress of the nitrosation reaction was monitored spectrophotometrically

by following the absorbance of S-nitrosocysteamine (CANO) at its experimentally
determined absorption peak of 545 nm where an absorptivity coefficient of 16.0 ± 0.1
M-1cm-1 was evaluated. Although CANO has a second absorption peak at 333 nm
with a much higher absorptivity coefficient of 536.0 M-1cm-1, its maximum
absorption at 545 nm was used due to lack of interference from the absorption peaks
of nitrogen species (NO2-, NO+ and HNO2) (see Figure 3.2).
The major reaction studied was a simple nitrosation of cysteamine through in
situ production of nitrous acid as the nitrosating agent. The yield of CANO varied,
based on order of mixing reagents (see Figure 3.3). The highest yield, which gave
quantitative formation of CANO, was obtained by pre-mixing nitrite with acid and
incubating the solution for approximately 1 s before subsequently reacting this nitrous
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acid with cysteamine in a third reagent stream of the double-mixing stopped-flow
spectrophotometer. The value of the absorptivity coefficient of CANO adopted for
this study of 16.0 M-1 cm-1 was derived from this mixing order. Pre-mixing CA with
acid before addition of nitrite gave a lower yield of CANO (trace (c)). The available
protons are reduced by the protonation of CA:

H2NCH2CH2SH + H+

[H3NCH2CH2SH]+

(R3.1)
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Figure 3.2:

UV/Vis spectral scan of (a) pure CA (0.01 M), (b) nitrite (0.001M), (c)

nitrous acid (0.001 M) and (d) CANO (0.001 M).
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Figure 3.3: Effect of order of mixing reactants (a) addition of 0.1 M CA to a
mixture of 0.005 M NO2- and 0.1 M H+ (b) addition of 0.1 M H+ to a mixture of
0.005 M NO2- and 0.1 M CA, and (c) addition of 0.005 M NO2- to a mixture of 0.1 M
H+ and 0.1 M CA.

This subsequently reduces the amount of immediately available nitrosating agent,
HNO2. The depression in CANO formed is exaggerated, as is the case in Figure 3.3
when CA concentrations exceed acid concentrations. In overwhelming excess of acid
over CA, the yields are nearly identical for both mixing formats. Most of these
reactions were run at pH conditions below 3.0; and at these conditions, it is assumed
that the CA exists in the protonated form at the nitrogen center. The second
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protonation on the thiol center is more relevant at even lower pH’s. Protolytic
reactions, in general, are very rapid and essentially diffusion-controlled. Retardation
of nitrosation and decrease in product for trace (c) is derived from the decrease in
protons as dictated, mathematically, by the equilibrium constant of reaction R3.1. On
the other hand, nitrous acid is a weak acid, and initial addition of acid to nitrite ensures
that protonated nitrite, the nitrosation species, remains in overwhelming majority over
unprotonated nitrite.

3.1.1

Stoichiometry
The stoichiometry of the reaction involves the reaction of 1 mol of

cysteamine (CA) with 1 mol of nitrous acid to produce 1 mol of S-nitrosocysteamine
(CANO) accompanied by the elimination of a water molecule and with the reaction
occurring solely at the thiol center (R3.2).

H2NCH2CH2SH + HNO2 → H2NCH2CH2S-NO + H2O

(R3.2)

The stoichiometry was derived by mixing excess solutions of perchloric acid
and nitrite with a fixed amount of cysteamine such that cysteamine was the limiting
reagent. The reaction was allowed to proceed to completion while rapidly scanning the
reacting solution between 200 nm and 700 nm. The maximum absorbances of the
resulting CANO at 333 nm and 545 nm were noted and concentration of CANO was
deduced from its maximum absorption at λmax of 545 nm where there was no
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possibility of interference from the absorption peaks of nitrogen species (NO2-, NO+
and HNO2) (Figure 3.2).

3.1.2

Product Identification
Product identification and verification was achieved by complementary

techniques: UV/vis spectrophotometry, HPLC, quadrupole time-of-flight mass
spectrometry and EPR spectrometry. CANO was identified by its distinct spectral
absorption peak at 333 nm with extinction coefficient of 536 M-1cm-1 and by another
peak at 545 nm with a smaller extinction coefficient of 16.0 M-1cm-1. It has a pink
color, which is consistent with the characteristic of primary S-nitrosothiols.158 1H
NMR analysis could not be used in the identification of this S-nitrosothiol as spectra
of CA and CANO were very similar, showing that the carbon skeleton of CA was not
disturbed by the nitrosation.
Time-of-flight mass spectrometry was used to prove that identity of product of
nitrosation was CANO and that of decomposition of CANO to be cystamine, a
disulfide of cysteamine. Scheme 3.1 shows all possible products of reaction. A
resolvable mass spectrum is taken at low acid concentrations, and this generally will
show both the reagent, CA, and the single product, CANO. This mass spectrum is
shown in Figure 3.4a. There are no other peaks that can be discerned from the
reaction mixture, apart from those belonging to the reagent and the product.
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Possible reactions of nitrous acid with cysteamine

Incubation of the product of nitrosation overnight shows a final conversion of the
CANO into the disulfide, cystamine (Figure 3.4b), H2NCH2CH2S-SCH2CH2NH2 .

2H2NCH2CH2S-NO → H2NCH2CH2S-SCH2CH2NH2 + 2NO

(R3.3)

The most important deduction from these spectra is the absence of any product from
possible reaction of the primary amine in CA with nitrous acid (Scheme 3.1). This is a
well known reaction in which nitrous acid reacts with a primary amine to yield
alcohols, alkenes and nitrogen via the formation of diazonium salt intermediate.159,160
The reaction conditions as well as high nucleophilicity of S-center may probably be
unfavorable for the formation of diazonium ion.
45

Figure 3.4: Mass spectrometry analysis of the product of nitrosation of CA showing
(A) formation of CANO, m/z = 107.9999. (B) Product of decomposition of CANO
after 24 hours. Cystamine, a disulfide of CA was produced with a strong peak, m/z =
153.0608

EPR Analysis: Nitric oxide can be trapped and observed by EPR techniques using a
nitroethane trap142. The aci-anion of this trap, generated in basic environments,
generates a long-lived spin adduct with NO, which is detectable and quantifiable by its
distinct ESR spectrum pattern and g-value:

CH3CH=NO2- + ·NO + OH- → [CH3C(NO)(NO2)]·2- + H2O

(R3.4)

The adduct [CH3C(NO)(NO2)]·2- is EPR-active. No peaks were obtained in the EPR
spectrum when the nitroethane trap was utilized during the formation of CANO,
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indicating that NO is not released during the S-nitrosation and that it is not a major
nitrosation agent in this mechanism that involves in situ production of HNO2. During
the decomposition of CANO, however, a strong EPR spectrum indicating the presence
of NO is obtained, proving stoichiometry R3.3. Figure 3.5 shows a series of EPR
spectra that proves presence of NO in the decomposition of CANO. The first three
spectra show that, on their own, nitroethane, CA, and NO2- cannot generate any active
peaks that can be attributed to NO.
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Figure 3.5: EPR spectra of NO radical generated during the decomposition of
CANO using 0.5 M nitroethane (NE) in 1.0 M NaOH solution as spin trap. (A) 0.5
M NE (B) 0.01 M NO2- (C) 0.04 M CA; [CANO] = (D) 0.01 M (E) 0.02 M (F)
0.03 M and (G) 0.04 M.
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In overwhelming excess of trap, the heights of the spectral peaks can be used, after a
standardization, as a quantitative measure of the available NO. NO has a very poor
solubility in water, and so the technique can be limited to only low NO concentrations.

3.1.3

Oxygen Effects
Figure 3.6 shows two nitrosation reactions at equivalent conditions except one

was run in solutions that had been degassed with argon and immediately capped.
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Figure 3.6:

Effect of oxygen on the nitrosation of CA: 0.005 M CA + 0.07 M NO2-

+ 0.08 M H+ ((a) Bubbled with argon (oxygen absent) and (b) Oxygen present).
Neither initial rates nor the final amounts of CANO formed are altered by the
absence or presence of oxygen.
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Argon’s heavier mass (over nitrogen), ensures that it can cover the top of the reagent
solutions, thereby ensuring that no further oxygen can enter into the reaction solution.
Similar results were obtained for these reactions. This might be expected when
nitrosation was not carried out via a direct reaction of nitric oxide and thiol, in which
oxygen reacts with nitric oxide to form nitrosating species (N2O3 and N2O4).161,162
These results agreed with what was obtained by Stubauer and co-workers in their
studies on nitrosation of bovin serum albumin (BSA) where yield of the S-nitrosothiol
formed was the same in the absence and presence of oxygen.162

3.1.4

Reaction Kinetics
The reaction has a simple dependence on cysteamine concentrations (see

Figures 3.7a and b). There is a linear first order dependence on the rate of nitrosation
with CA concentrations with an intercept kinetically indistinguishable from zero, as
would have been expected. The reaction kinetics are more reproducible in the format
utilized in Figure 3.7 in which concentrations of acid and nitrite are equal and in
overwhelming excess over CA concentrations. Effect of nitrite is also simple and first
order (see Figures 3.8a and b) when nitrite concentrations do not exceed the initial
acid concentrations such that effectively all N(III) species in the reaction environment
are in the form of protonated HNO2. As expected, acid effects are much more
complex and are dependent on the ratio of initial acid to nitrite concentrations. The
nitrosation’s response to acid differs, depending on whether initial proton
concentrations exceed initial nitrite concentrations.
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Figure 3.7a: Absorbance traces showing the effect of varying CA concentrations.
The reaction shows first-order kinetics in CA. [NO2-]0 = 0.10 M; [H+]0 =0.10 M;
[CA]0 = (a) 0.005 M, (b) 0.006 M, (c) 0.007 M, (d) 0.008 M, (e) 0.009 M, and (f)
0.010 M.
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Figure 3.7b: Initial rate plot of the data in Figure 3.7a. The plot shows the strong
first –order dependence of the rate of formation of CANO on CA.
The most important parameter affecting rate of nitrosation is the concentration of
HNO2. The kinetics traces shown in Figure 3.9a encompass a proton concentration
variation that ranges from concentrations that are lower than nitrite to those that
exceed. A simple plot of added acid to the rate of nitrosation shown in Figure 3.9b
clearly displays this discontinuity at the point where acid exceed nitrite concentrations.
By utilizing the dissociation constant of HNO2, the final concentrations of H3O+, NO2-,
and HNO2 can be calculated for each set of initial concentrations. These data are
shown in Table 3.1 for the input concentrations used for Figure 3.9c. Close
examination of the data in Table 3.1 shows that the kinetics of reaction are vastly
different depending on whether initial acid concentrations exceed initial nitrite
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concentrations. When nitrite is in excess (the first four readings), there is a sharp
nonlinear increase in rate of nitrosation with nitrous acid concentrations (Figure 3.9c),
and a saturation in rate with respect to the actual proton concentrations despite the
recalculation of the concentrations undertaken in Table 3.1. Figure 3.9c would
strongly indicate second order kinetics in nitrous acid, and a plot of nitrosation rate vs
nitrous acid to the second power is linear (Figure 3.9c insert). Table 3.1 shows that, in
the series of data plotted for Figure 3.9c, nitrous acid concentrations and excess proton
concentrations increase while nitrite concentrations decrease; and the final observed
on rate of nitrosation is derived from these three species concentration changes and not
isolated to nitrous acid. At acid concentrations that exceed initial nitrite
concentrations, there is a linear dependence in rate on acid concentrations (Figure
3.9d), but a saturation would have been achieved in nitrous acid concentrations as
would be expected in this format in which the nitrous acid saturates at 50 mM. The
increase in nitrosation rate with increase in acid after saturation of HNO2 indicates that
other nitrosants exist in the reaction environment apart from HNO2.
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Figure 3.8a: Absorbance traces showing the effect of varying nitrite concentrations.
The reaction shows first-order kinetics in nitrite. [CA]0 = 0.10 M; [H+]0 = 0.10 M;
[NO2-]0 = (a) 0.005 M, (b) 0.006 M, (c) 0.007 M, (d) 0.008 M, (e) 0.009 M, and
(f) 0.010 M.
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Figure 3.8b: Initial rate plot of the data in Figure 3.8a. The plot shows strong
dependence on initial rate of formation of CANO on nitrite.
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Figure 3.9a: Absorbance traces showing the effect of varying acid concentrations.
[CA]0 = 0.05 M; [NO2-]0 = 0.05 M; [H+]0 = (a) 0.01 M, (b) 0.02 M, (c) 0.04 M, (d)
0.05 M, (e) 0.06 M, and (f) 0.07 M.
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Figure 3.9b: Plot of the raw kinetics data in Figure 3.9a for the effect of added acid
on the rate of nitrosation. Acid concentrations plotted here are those experimentally
added, and not calculated.
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region at which initial nitrite concentrations exceed acid concentrations.
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Table 3.1: Input species concentrations and final reagent concentrations for acid
dependence experiments. (units of M)

[H+]added

[NO2-]added

[HNO2]initial

[NO2-]final

[HNO2]final

[H3O+]final

0.01

0.05

0.01

4.01x10-2

9.86x10-3

1.38x10-4

0.02

0.05

0.02

3.04x10-2

1.97x10-2

3.63x10-4

0.03

0.05

0.03

2.92x10-2

7.90x10-4

0.04

0.05

0.04

3.82x10-2

1.82x10-3

0.05

0.05

0.05

4.50x10-2

5.03x10-3

0.06

0.05

0.05

4.78x10-2

1.22x10-2

0.07

0.05

0.05

4.78x10-2

2.13x10-2

0.08

0.05

0.05

4.91x10-2

3.09x10-2

2.08x10-2

1.18x10-2
5.03x10-3

2.22x10-3
1.29x10-3

8.93x10-4
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Figure 3.9d: Plot showing the linear dependence of rate of formation of CANO on
[H3O+] in high acid concentrations where initial acid concentrations exceed nitrite
concentrations. Nitrous acid concentrations are nearly constant in this range.

Catalytic Effect of Copper
Copper is a trace element that is highly essential for life by being a cofactor for
the function of many enzymes such as cytochrome c oxidase, dopamine
monooxygenase and the enzyme involved in the removal of reactive oxygen species
(superoxide dismutase).163,164 Depending on the redox environment, copper can cycle
between two states, reduced Cu+ and oxidized Cu2+, allowing it to play its numerous
physiological roles.165 It has been implicated in many reactions involving
organosulfur compounds. Cu(I) is known to be much more active than Cu(II). It is
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easier to assay for Cu(II) and addition of Cu(II) to organosulfur reactions involves its
initial conversion to the more active Cu(I).166,167 Figure 3.10a shows that addition of
Cu(II) rapidly increases the nitrosation reaction. Cu(II) ions, however, also catalyze
the decomposition of CANO. A plot of rate of nitrosation versus Cu(II)
concentrations shows the sigmoidal rate increase followed by an abrupt saturation,
which is typical of catalytic mechanisms (Figure 3.10b). No nitrosation occurs in the
presence of nitrite without acid (which is necessary to generate the HNO2). Figure
3.10c shows that, even in the absence of acid, Cu(II) ions can still effect the
nitrosation of CA, even though this nitrosation is slow. Cu(I) ions, however, could not
effect nitrosation in the absence of acid. Figure 3.10d shows the catalytic effect of
Cu(II) ions on the decomposition of CANO. CANO was prepared in situ from two
feed streams of the stopped flow ensemble. Cu2+ was next added from a third feed
stream (buffered at pH 7.4) after complete production of CANO. The two control
experiments (traces a and b) show the slow decomposition expected from CANO
solutions at pH 7.4. Trace b is treated with EDTA to sequester all metal ions in the
reaction solution. This trace is identical to the one without EDTA confirming the
absence of metal ions in reagent solution which can affect the decomposition kinetics.
Addition of micromolar quantities of Cu(II) ions effects a big acceleration in rate of
decomposition. Higher Cu(II) concentrations gave a strong autocatalytic decay of the
nitrosothiol (trace f in Figure 3.10d).
The catalytic effect of Cu(II) ions on the decomposition can also be evaluated
through the rate of production of nitric oxide which is known to be the major product,
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together with the disulfide, of nitrosothiol decompositions. Figure 3.10e shows EPR
spectra using the nitroethane trap, of the enhanced production of NO with addition of
Cu(II) ions. All three spectra were taken after the same time lapse from CANO
incubation, and thus the peak heights of the NO-induced spectra can be correlated with
extent of reaction.
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Figure 3.10a: Absorbance traces showing the effect of varying Cu2+ concentrations
on the rate of formation of CANO. There is a progressive increase in the rate of
CANO formation with increase in Cu2+ concentration. [CA]0 = [NO2-]0 = [H+]0 =
0.05 M; [Cu2+]0 = (a) 0.00 M, (b)5 µM, (c) 15 µM, (d) 100 µM, (e) 1 mM, and (f)
2.5 mM.
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Figure 3.10c: Absorbance traces showing the formation of CANO via a reaction of
CA, nitrite and copper (II) without acid. The amount of CANO formed increases
with increase in Cu2+ concentrations. No formation of CANO was observed with
Cu+. The result shows catalytic effect of Cu2+ on the rate of formation of RSNO.
[CA]0 = [NO2-]0 = [H+]0 = 0.05 M; [Cu2+] = (a) 0.0025 M, (b) 0.0030 M, (c) 0.0035
M, (d) 0.0040 M, (e) 0.0045 M, and (f) 0.0050 M.
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Figure 3.10d: Effect of Cu2+ on the stability of CANO in a pH 7.4 phosphate buffer.
This reaction involves the reduction of Cu2+ to Cu+, which causes the decomposition
of CANO. [CANO]0 = 0.028 M; [Cu2+]0 = (a) 0.00 M (pure CANO), (b) 0.00 M
(pure CANO in 0.00001 M EDTA), (c) 5 µM, (d) 10 µM, (e) 20 µM, and (f) 30 µM.
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Figure 3.10e: EPR spectra of NO radical showing the catalytic effect of Cu2+ on the
rate of decomposition of CANO. The intensity of the spectra increases with increase
in Cu2+ concentration. [CANO]0 = 0.01 M, [Cu2+]0 = (a) 0.00 (b) 1.0 x 10-4 M (c)
2.0 x 10-4 M.

Transnitrosation
The most abundant thiol in the physiological environment is glutathione, GSH. A
pertinent reaction to study would be the interaction of any nitrosothiol formed in the
physiological environment with glutathione. This is due to GSH’s sheer abundance
which overwhelms the other thiols. A crucial question is the lifetimes of the
nitrosothiols formed. If thiols are carriers of NO from point of production to point of
its usage, the nitrosothiols formed should be stable enough and have a long enough
half-life to enable them to perform this activity.
63

1.0

d

0.025

c

545 nm
c

0.020

0.8

590nm
d

Absorbance

0.015
0.6

a,b

0.010

b

0.005

a
0.4

0.000
400 450 500 550 600 650 700

0.2

545 nm

590 nm

0.0
200

300

400

500

600

700

Wavelength (nm)

Figure 3.11a: Superimposed spectra of four well known nitrosothiols (a) CysNO, (b)
CANO, (c) GSNO and (d) SNAP (nitrosothiol of penicillamine). Three of them
nearly have the same ε at 545 nm. The observed separation in the absorbances af
these three at 545 nm is due to staggering the time lag before acquiring the
spectrum.

Spectrophotometric study of transnitrosation is rendered complex by the fact that
many nitrosothiols seem to absorb at the same wavelength; with similar absorptivity
coefficients. Figure 3.11a shows a series of superimposed spectra of four well-known
nitrosothiols which show nearly identical spectra. Figure 3.11b shows the
64

spectrophotometric characterization of possible transnitrosation in mixtures of CANO
and glutathione, GSH. GSNO has a higher absorptivity coefficient than CANO at the
same wavelength, and this explains the initial increase in absorbance on addition of
GSH to CANO. LC-MS data have shown that the reaction mixture can contain any of
at least 6 components at varying times and concentrations: CANO, GSNO, GSH, CACA (cystamine), GSSG (oxidized glutathione) and CA-GS (mixed disulfide). The rate
of transnitrosation will be difficult to evaluate due to the presence of the mixed
disulfide. Figure 3.11b shows that, relatively, CANO is more stable than GSNO due
to the rapid rate of consumption of GSNO upon its formation as compared to the much
slower CANO decomposition with or without EDTA. Figure 3.11c shows a GC-MS
spectrum of mixtures of CANO and GSH. This involved a 3:5 ratio of CANO to
GSH, which is also trace f in Figure 3.11b. The remarkable aspect of this spectrum is
the absence of the oxidized glutathione, GSSG, whose precursor is GSNO. Thus
GSNO, when formed, rapidly decomposes by reacting with CA to form the mixed
disulfide and releasing NO. The cystamine formed and observed in the spectrum is
derived from the normal decomposition of CANO (R3.5).

H2NCH2CH2SNO → H2NCH2CH2S-SCH2CH2NH2 + NO

R3.5

In order to demonstrate more clearly the transnitrosation reactions between CA and
other RSNOs, S-nitroso- N-acetyl-D-penicillamine (SNAP) was employed because it
absorbs at different wavelength (590 nm) from CANO, which absorbs at 545 nm.
65

Quantitative formation of CANO was obtained within 1 min in the reaction involving
excess CA and SNAP. In the visible regions of the spectrum the reaction mixture
showed decomposition of SNAP at 590 nm and simultaneously formation of CANO at
545 nm.
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Figure 3.11b: The effect of glutathione (GSH) on the stability of CANO in a pH 7.4
phosphate buffer. All experimental traces have [CA]0 = 0.03 M, [NO2-]0 = 0.03 M,
and [H+]0 = 0.05 M. [GSH] = (a) 0, (b) 0, (c) 0.01 M (d) 0.02 M (e) 0.03 M and (f)
0.05 M. Trace a and b are the control. Trace a has no EDTA. Trace b is the same as
trace a with 10 µM. EDTA. No significant difference between traces a and b,
indicating that the water used for preparing reagent solutions did not contain
enough trace metal ions to affect the kinetics. 10 µM. EDTA is added to reactions in
traces c, d, e and f.
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Figure 3.12a shows visible multiple spectra scan taken at every 1.0 seconds. The effect
of CA on the transnitrosation reaction is shown in Figure 3.12b.

Figure 3.11c: A LC-MS spectrum of a 3:5 ratio of CANO to GSH; trace f in Figure
3.11b. Final products were predominantly the mixed disulfide and cystamine with
no evidence of GSSG.

67

The amount of CANO produced is proportional to the amount of SNAP decomposed
(R3.6 - R3.8).

NAP- + NO+

SNAP
CA

CA- + H+

NO+ + CA-

R3.6
pKa(SH) = 10.75

CANO

R3.7
R3.8

Plots of initial rate of formation of CANO at 545 nm (Figure 3.12ci) and
decomposition of SNAP at 590 nm (Figure 3.12cii) gave linear plots indicating firstorder dependence on the initial concentrations of CA. In another series of studies, the
effect of varying SNAP on its reaction with CA to form CANO was investigated. As
expected, the rate of transnitrosation increases with increase in the initial
concentrations of SNAP (Figure 3.12d). First-order kinetics was obtained upon
plotting the initial rate of formation of CANO versus the initial concentrations of
SNAP (Figure 3.12e).
A further confirmatory evidence for the transnitrosation was achieved by
electrospray ionization mass spectrometry (ESI-MS) technique. Figure 3.12f shows
that the product of the transnitrosation contains a mixture of components including
CANO, N-acetyl-D-penicillamine (NAP) disulfide, and mixed disulfide of CA and
NAP.
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Figure 3.12a: Repetitive spectral scan of the reaction of SNAP with excess
cysteamine (CA) at pH 7.4 showing consumption of SNAP at 590 nm and formation
CANO at 545 nm. [CA] = 0.025 M; [SNAP] = 0.0025 M.
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Figure 3.12b: Absorbance traces showing the effect of varying CA concentrations
on its transnitrosation by SNAP. The plot shows both formation of CANO at 545 nm
(dotted lines) and decomposition of SNAP at 590 nm (solid lines). [SNAP]0 = 0.0049
M; [CA]0 = (a) 0.005 M, (b) 0.0075 M, (c) 0.01 M, (d) 0.02 M, (e) 0.03 M, (f) 0.04 M
and (g) 0.05 M.
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Figure 3.12cii: Initial rate plot of the data in Figure 3.12b. The plot shows linear
dependence on initial rate of decomposition of SNAP on CA in the transnitrosation
of CA by SNAP.
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Figure 3.12d: Absorbance traces showing the effect of varying SNAP
concentrations on its transnitrosation of CA. The plot shows both formation of
CANO at 545 nm (dotted lines, a1-e1) and decomposition of SNAP at 590 nm (solid
lines, a-e). [CA]0 = 0.03 M; [SNAP]0 = (a) 0.00503 M, (b) 0.00626 M, (c) 0.00700
M, (d) 0.00808 M and (e) 0.00883 M
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Figure 3.12e: Initial rate plot of the data in Figure 3.12d. The plot shows linear
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Figure 3.12f: A LC-MS spectrum of a 1:3 ratio of SNAP to CA; trace e in Figure
3.12d.
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MECHANISM
The overall rate of nitrosation is dependent on the rate of formation and
accumulation of the nitrosating agents. A number of possibilities have been
suggested, and these include HNO2, NO, NO2, N2O3 and the nitrosonium cation, +NO.
Some nitrosants cannot exist under certain conditions: for example, the nitrosonium
cation cannot exist at high pH conditions and NO2 cannot exist in strictly anaerobic
conditions except in aerobic environments where it can forms from NO and
subsequently N2O3 will also be formed 168.

NO + 1/2O2 → NO2

(R3.9)

NO + NO2 → N2O3

(R3.10)

Both NO2 and N2O3 are potent nitrosating agents. There is a slightly higher rate of
nitrosation in aerobic environments compared to anaerobic (Figure 3.6). This is a
reflection of the low dissolved oxygen concentrations available in aqueous solutions at
approximately 2x10-4 M. Thus, though the formation for these nitrosants is favored,
their viability is hampered by the low concentrations of oxygen as well as NO, which
is only produced during the decomposition of the nitrosothiol. No NO was detected
during the formation of CANO. In this aqueous environment utilized for these
experiments, the reaction of aqueous N2O3 to nitrous acid would be overwhelmingly
dominant. This is a rapid equilibrium reaction that favors the weak acid, HNO2:

74

N2O3(aq) + H2O(l)

2HNO2(aq); KH

(R3.11)

Early studies by Bunton and Steadman 169 had erroneously estimated a value for KH-1
= 0.20 M-1; which would indicate appreciable amounts of N2O3 (aq) over nitrous acid.
A more accurate evaluation by Markovits et al 170 gave a more realistic value of KH-1 =
3.03 ± 0.23 x10-3 M-1. Most nitrosation studies in aerobic NO environments neglect
the contribution to nitrosation by NO2 and only concentrate on NO and N2O3
nitrosations. NO2 concentration will always be negligibly low because of reaction
R3.10, which is two orders of magnitude greater than the rate of nitrosation by NO2;
1.1 x 109 M-1 s-1 vs 2.0 x 107 M-1 s-1 respectively 171,172.
All nitrosation kinetics show first order dependence in both the thiol (CA, in
this case), and nitrite and a slightly more complex dependence on acid. Data in
Figures 3.7 and 3.8 show this strong first order dependence on CA and on nitrite. In
conditions in which acid concentrations are less than initial nitrite concentrations, the
effect of nitrite is more difficult to interpret since a change in its concentrations
concomitantly induces a change in both acid and HNO2 concentrations, and thus its
sole effect cannot be isolated. First order kinetics in nitrite strongly suggests that the
major nitrosant, at the beginning of the reaction is HNO2 since there is a direct
correlation between nitrite concentrations and HNO2, especially when there is
consistently excess acid over nitrite. After performing calculations for the relevant
reactive species in the reaction medium (Table 3.1), the plot of initial rate of
nitrosation vs. nitrous acid concentrations that shows a parabolic dependence
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erroneously suggests second order kinetics in HNO2 (Figures 3.9b and 3.9c) for the
region in which nitrite concentrations exceed acid. As mentioned in the Results
section, data in Table 3.1 show that HNO2 is not changing in isolation. Both nitrite
and acid are also concomitantly changing, and so the effect observed in rate is not
solely due to changes in HNO2 concentrations. When acid is in excess over nitrite, the
amount on HNO2 saturates, but as can be seen in Figure 3.9d, the rate keeps increasing
in a linear way with increase in acid; indicating the presence of multiple nitrosating
agents apart from HNO2. The simplest rate law that can explain this nitrosation rate
involves the nitrosonium cation (NO+) and HNO2. The nitrosonium cation can be
formed from the protonation of HNO2:

HNO2 + H3O+

H(OH)N=O+ + H2O; Kb

(R3.12)

(H(OH)N=O+ is a hydrated nitrosonium cation, +NO + H2O)
Overall rate of reaction, using these two nitrosants gives:

 [ H + ][ N ( III )]T
Rate = 
+
 [H ] + K a


[CA] k1 + k 2 K b [ H + ]



[

]

(1)

Where [N(III)]T is the total of nitrous acid and nitrite concentrations as calculated in
Table 3.1, columns 4 and 5 and [H+] is the calculated acid in Column 6. Ka is the acid
dissociation constant of nitrous acid and Kb is the equilibrium for the protonation of
nitrous acid (Reaction R3.12). k1 is the bimolecular rate constant for the nitrosation of
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CA by HNO2 and k2 is the bimolecular rate constant for the nitrosation by the
nitrosonium cation. Ka was taken as 5.62x10-4 M-1; and thus, at high acid
concentrations, a plot of Rate/[N(III)]T[CA] vs. [H+] should give a straight line with
slope k2Kb and intercept k1. This type of plot only applies to conditions of excess acid
over nitrite (Figure 3.9d). One can derive values for k1 and product k2Kb from these
series of plots. A value of k1 = 17.9 M-1 s-1 was derived from a series of several
complementary experiments. k2 was deduced as 8.25 x 1010 M-1 s-1 after assuming a
Kb value of 1.2 x 10-8 M-1.

Decomposition of CA: S-nitrosothiols, RSNOs, differ greatly in their stabilities, and
most of them have never been isolated in solid form. Homolysis of the S-N bond
occurs both thermally and photochemically, but, generally, these processes are very
slow at room temperatures and in the absence of radiation of the appropriate
wavelength. In vivo decomposition of RSNOs is likely to proceed through other
pathways apart from these two. Presence of trace amounts of Cu(II) or Cu(I) can
efficiently catalyze RSNOs to disulfide and nitric oxide (see Figures 3.10 a – d):

2RSNO → RSSR + 2NO

(R3.13)

CANO is a primary S-nitrosothiol, and primary and secondary nitrosothiols are
generally known to be unstable compared to tertiary nitrosothiols. S-nitroso-N77

acetylpenicillamine is the most well known stable tertiary nitrosothiol 173. The
mechanism of decomposition of nitrosothiols was believed to proceed through the
homolytic cleavage of this weak S – N bond. Computed S-N bond dissociation
energies for nitrosothiols show very little variation, however, between primary,
secondary and tertiary nitrosothiols; resulting in very similar homolysis rates of
reaction at elevated temperatures for all nitrosothiols. The computed activation
parameters for thermal homolysis to occur are prohibitively high for this to be a
dominant pathway under normal biological conditions. For example, assuming an
approximate S-N bond energy of 31 kCal, a rough calculation will indicate that if
decomposition was to proceed solely through homolysis, the half-life of a typical
nitrosothiol would be in the regions of years instead of the minutes to hours that are
observed 174. This analysis does not support the work reported by Roy et al 175 in
which they established homolysis as the major decomposition pathway. They also
managed to trap the thiyl radical, RS·. Close examination of their reaction conditions
show high trap concentrations (0.2 M DMPO) and nitrosothiol (0.1 M). Such
conditions would catch even very low concentrations of thiyl radical, but would not
necessarily indicate that this was the dominant pathway and whether it was derived
solely from hemolytic cleavage of the S-N bond. Nitrosothiol decompositions in the
absence of metal ions are mostly zero order (see traces a, b in Figure 3.10d); and this
is inconsistent with an S-N bond homolysis-driven decomposition 176; which would
have been expected to be first order. In the presence of excess thiol, however,
decomposition of nitrosothiols proceeds via a smooth first order decay process 173.
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For a series of nitrosothiols, the homolysis-dependent decomposition rates are not
dependent on the bulkiness of the substituent groups attached to the nitrosothiols,
which seems to enhance calculations that showed no discernible difference in the S-N
bond energies irrespective whether the nitrosothiol was primary, secondary or tertiary
177,178

. In aerated solutions, the decay was autocatalytic, thus implicating N2O3 as the

autocatalytic propagating species (see reactions R3.9 + R3.10) 177. Nitrosothiol
decompositions were much slower in solutions in which NO was not allowed to
escape by bubbling argon; implicating NO as a possible retardant of nitrosothiol
decomposition. This can be explained by the recombination of the thiyl radical with
NO in the reaction cage after initial cleavage. Elimination of NO from the scene by
bubbling air, forces reaction R3.14 to the right. No mechanism has yet been proposed
for the implication of N2O3 in the autocatalytic mechanism. One can assume that
N2O3 should assist in the cleavage of the S-N bond; thus accelerating rate of homolytic
decomposition of RSNO’s by lowering S-N bond energy and subsequently the
activation energy.

RSNO

RS· + NO

(R3.14)

In aerated solutions, NO then undergoes reactions R3.9 + R3.10 to yield N2O3.

RSNO + N2O3 → RSN(NO2)O· + NO

(R3.15)
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The incorporation of the NO2- group in the nitrosothiol would weaken the S-N bond;
leading to its easy cleavage and re-generation of the N2O3 molecule which will
proceed to further catalyze the decomposition.

RSN(NO2)O· → RS· + N2O3

(R3.16)

The sequence of R3.14 – 3.16 will deliver quadratic autocatalysis in N2O3.
Recent results have suggested a novel pathway for the decomposition of
nitrosothiols which involves an initial internal rearrangement to form an N-nitrosation
product 179. Typical nitrosothiol decomposition products after such an internal rearrangement would include thiiranes and 2-hydroxy-mercaptans. This mechanism has
been used successfully to explain the production of a small but significant quantity of
2-hydroxy-3-mercaptopropionic acid (apart from the dominant product cystine), in the
decomposition of S-nitrosocysteine. GC-MS spectrum shown in Figure 3.4, however,
gives a dominant signal for dimeric cystamine, with very little evidence of any other
significant products, indicating very little initial N-transnitrosation.
The copper-catalyzed decomposition of nitrosothiols has been welldocumented. Other metal ions have also been implicated in this catalysis. The varying
rates of nitrosothiol decompositions reported by different research groups can be
traced to adventitious metal ion catalysis from the water used in preparing reagent
solutions. Even in this case, with the maximum metal ion concentrations of 0.43 ppb
in Pb2+, small differences can be observed between EDTA-laced reaction solutions
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and those that are not (see traces a, b in Figure 3.10d and traces a, b in Figure 3.11b).
Nitrosothiol decompositions have also implicated other metal ions and not just
specifically copper 180. Though Cu(II) ions are used to catalyze nitrosothiol
decomposition, the active reagent is Cu(I). In this catalytic mechanism, Cu redoxcycles between the +2 and +1 states. Only trace amounts of Cu(I) are needed to effect
the catalysis, and these can be generated from the minute amounts of thiolate anions
that exist in equilibrium with the nitrosothiol:

RSNO

RS- + NO+

(R3.17)

2Cu2+ + 2RS- → RSSR + 2Cu+

(R3.18)

Cu+ + RSNO → [RS(Cu)NO]+

(R3.19)

[RS(Cu)NO]+ → RS- + NO + Cu2+

(R3.20)

The cascade of reactions R3.17 – R3.20 continues until the nitrosothiol is depleted and
converted to the disulfide. The complex formed in reaction R3.19 is well known and
justified through density functional theory that reports that Cu+ binds more strongly to
the the S center than to the N center of the nitrosothiol 181. This preferential binding
weakens and lengthens the S-N bond, thus facilitating its cleavage. It is difficult to
extrapolate this proposed mechanism into the physiological environment, but some
experimental results have shown that protein-bound Cu2+ catalyzed nitric oxide
generation from nitrosothiols, but not with the same efficiency as the free, hydrated
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ion 182. Further studies are needed to evaluate the efficiency of this catalysis especially
in copper-based enzymes.

Effect of Cu(II) on Nitrosation of Cysteamine (Figure 3.10c)
The fact that Cu(II) ions can assist in nitrosating CA from nitrite in the absence of acid
while Cu(I) ions are unable to effect this can be explained by recognizing that
nitrosation is an electrophilic process, where NO effectively attaches as the (formally)
positive charge, while eliminating a positively charged proton. Cu(II), in this case,
acts by complexing to the nitrite and forming a nitrosating species which will release
the Cu(II) ions after nitrosation.
O
Cu2+ + NO2-

Cu

+
N

O

Further Experiments on Effect of Nitrous Acid
Since it appears that nitrous acid is the major nitrosation species, another series of
experiments were undertaken in which the effect of nitrous acid can be unambiguously
determined. For the data shown in Figure 3.13a, nitrite and acid were kept at
equimolar concentrations and varied with that constraint. Final acid and nitrite
concentrations after dissociation, are also equal for electroneutrality (see Table 3.2).
Thus, if our simple mechanism is plausible, a plot of nitrous acid vs initial nitrosation
rate should be linear with expected slight tailing at either extreme of the nitrous acid
concentrations from nonlinear generation of free acid due to the quadratic equation.
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Using the same rate law as Equation (1), a value of k1 can be derived and compared
with values obtained from plots of type Figure 3.9d. Kinetics constants derived from
plots of type Figure 3.13b are not expected to be as accurate as those from Figure 3.9d,
but should deliver values close to those from high acid environments. In the limit of
only nitrous acid as the nitrosating agent (too low a concentration of excess H3O+ to
effect equilibrium of reaction R3.11), data derived from Figure 3.13b delivered an
upper limit rate constant for k1 that was higher than that derived from Figure 3.9d-type
data, but well within the error expected for such a crude extrapolation. In order to fully
establish the observed effect of acid, another set of experiments similar to experiments
in Figure 3.13a, but at pH 1.2 in phosphate buffer system were conducted (Figures
3.14a and b). Other sets of kinetics data were derived in which CA concentrations
were varied while keeping the nitrous acid concentrations constant. Varying nitrous
acid concentrations were used, and for each, a CA-dependence was plotted (data not
shown). These were straight lines, through the origin, and with the slope determined
by the concentration of nitrous acid and the free protons existing in solution after the
dissociation of nitrous acid. For these kinetics data, equation (1) had to be evaluated
completely since Ka ≈ [H3O+] and no approximation could be made.
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Figure 3.13a: Evaluation of unambigous nitrous acid dependence by employing
[H+]0 = [NO2-]0 and varying both at the same equimolar concentrations. [CA]0 fixed
at 0.025 M. And [H+]0 = [NO2-]0 = (a) 0.005 M; (b) 0.010 M; (c) 0.015 M; (d) 0.020
M; (e) 0.025 M; (f) 0.030 M; (g) 0.035 M
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Table 3.2: Input species concentration and final reagent concentrations (mol L-1)
for nitrous acid dependence experiments with [H+]0 = [NO2-]0

[H+]added
(mol L-1)

[NO2-]added
(mol L-1)

[HNO2]initial
(mol L-1)

[H3O+]final
(mol L-1)

[NO2-]final
(mol L-1)

[HNO2]final
(mol L-1)

5.00 x 10-3

5.00 x 10-3

5.00 x 10-3

1.42 x 10-3

1.42 x 10-3

3.58 x 10-3

1.00 x 10-2

1.00 x 10-2

1.00 x 10-2

2.11 x 10-3

2.11 x 10-3

7.89 x 10-3

1.50 x 10-2

1.50 x 10-2

1.50 x 10-2

2.64 x 10-3

2.64 x 10-3

1.24 x 10-2

2.00 x 10-2

2.00 x 10-2

2.00 x 10-2

3.08 x 10-3

3.08 x 10-3

1.69 x 10-2

2.50 x 10-2

2.50 x 10-2

2.50 x 10-2

3.48 x 10-3

3.48 x 10-3

2.15 x 10-2

3.00 x 10-2

3.00 x 10-2

3.00 x 10-2

3.83 x 10-3

3.83 x 10-3

2.62 x 10-2

3.50 x 10-2

3.50 x 10-2

3.50 x 10-2

4.16 x 10-3

4.16 x 10-3

3.08 x 10-2

The values of k1 and k2Kb were utilized in equation (1) to recalculate initial rates and
slopes with respect to CA concentrations. These values were utilized to check the
accuracy of the kinetics constants derived from high acid dependence experiments. It
was noted that, within experimental error, these values checked and were generally
robust.
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Figure 3.13b: Plot of initial rate of nitrosation vs initial nitrous acid concentrations
as calculated in Table 3.2 and derived from the data in Figure 3.13a.
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Figure 3.14a: Absorbance traces showing the effect of varying nitrous acid
concentrations at pH 1.2 in phosphate buffer. [CA]0 = 0.05 M; [NO2-]0 = [H+]0 = (a)
0.005 M, (b) 0.01 M, (c) 0.015 M, (d) 0.02 M, (e) 0.025 M, (f) 0.03 M, (g) 0.035 M.
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Figure 3.14b: Plot of initial rate versus nitrous acid concentrations of the
experimental data in Figure 3.14a

Simulations:
A very small set of simple reactions was utilized to simulate the nitrosation kinetics.
This is shown in Table 3.3. At low acid concentrations, the nitrosation is dominated
by HNO2 as the nitrosant, and as acid concentrations are increased, both nitrous acid
and the nitrosonium cation are involved in the nitrosation.
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Table 3.3: Mechanism used for simulating the nitrosation of cysteamine. RSH
stands for cysteamine.
Reaction

Reaction

kf; kr

No.
M1

H+ + NO2-

HNO2

1.10 x 109 M-1s-1; 6.18 x 105 s-1
(Ka(HNO2) = 5.62 x 10-4)

M2

2HNO2

N2O3 + H2O

1.59 ± 0.50 M-1s-1; 5.30 x 102 s-1
(KM2 = 3.0 x 10-3 M-1)

M3

HNO2 + H+

+

N=O + H2O

4.00 x 101 M-1s-1; 3.33 x 109 s-1
(KM3 = 1.2 x 10-8 M-1)

M4

RSH + HNO2 → RSNO + H2O

M5

RSH + +N=O

M6

N2O3

M7

2RSNO

M8

RSNO + H+
NO + NO2
RSSR + 2NO

RSH + N2O3 → RSNO + HNO2

17.9 M-1s-1; ca. 0
8.25 x 1010 M-1s-1; 3.6 x 103 M-1s-1
8.0 x 104 s-1; 1.1 x 109 M-1s-1
5.0 x 10-2 M-1s-1; ca. 0
9.49 x 103 M-1s-1; ca. 0

Even though Table 3.3 includes nitrosation by N2O3; the lack of oxygen
(approximately kept constant at 2.0x10-4 M and its most favored and rapid reaction to
nitrous acid made the nitrosation by N2O3 insignificant. Its insignificant concentration
ensured that the simulations were very insensitive to the value of the bimolecular
nitrosation constant for N2O3; kM8. Figure 3.15b clearly shows that concentration of
N2O3 never rises to a level where it would be significant. The rate constants adopted
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for reaction M1 were unimportant for as long as they were fast (in both directions),
and were connected by the acid dissociation constant, Ka. Increasing the forward and
reverse rate constants while maintaining Ka only slowed the simulations, but did not
alter the results. Reaction M2 was also a rapid hydration reaction which strongly
favored HNO2; thus rapidly depleting any N2O3 formed, or merely keeping these
concentrations depressed should the tandem of reactions R3.9 + R3.10 have been
added to the mechanism. These were not utilized for this simulation because EPR had
not detected any NO at the beginning of the reaction, and only detected NO during the
decomposition of the nitrosothiol. There are no reliable thermodynamics parameters
for reaction M3 since this would be heavily-dependent on the pH of the medium. For
the purposes of this simulation and some of our previous estimates, the equilibrium
constant for M3 was set at 1.2 x 10-8 M-1. Kinetics constants for M4 and M5 were
derived from this study. In the absence of significant concentrations of N2O3; the
simulations are insensitive to the kinetics constants utilized for reactions M6 and M8.
Reaction M8 was assumed to be slow, and in the absence of Cu(II) ions or other
adventitious ions, this is indeed so (see Figures 3.10a and c). The simulations are
shown in Figure 3.15a, which gives a reasonably good fit from such a crude
mechanism. Figure 3.15b is provided to show the concentration variation of some of
the species that could not be experimentally determined. Of note is that N2O3
concentrations are depressed throughout the lifetime of the nitrosation. Even though
the nitrosonium cation is also depressed in concentration; this can be explained by its
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Figure 3.15a: Simulation of the short mechanism shown in Table 3. Solid lines are
experimental data while the symbols indicate simulations. The mechanism is
dominated by the value of k1. [CA]0 = [NO2-]0 = 0.05 M.
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Figure 3.15b: Results from the modeling that delivered simulations of the two
traces shown in Figure 3.15a. These simulations show the concentration variations
of those species that could not be experimentally monitored. Neither N2O3 nor NO+
rise to any significant concentration levels.
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high rate of nitrosation as soon as it is formed, and an equilibrium that favors its
hydration back to HNO2 once the thiol is depleted.

Conclusion.
This detailed kinetics study has shown that even though there are several possible
nitrosating agents in solution, in the physiological environment, with its slightly basic
pH and low oxygen concentrations; the major nitrosant is HNO2. Furthermore, the
lifetime of CANO is not long enough to be able to be effectively used as a carrier of
NO. GSH, which has been touted as a possible carrier of NO, appears to be have a
lower lifetime than CA. However, its overwhelming concentration in the
physiological environment might still be a better carrier of NO than other thiols.
Protein thiols, it appears would be best carriers by either intra- or intermolecular
transfer of NO.
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CHAPTER 4
KINETICS AND MECHANISMS OF FORMATION OF
S-NITROSOCYSTEINE
4.0 INTRODUCTION
Cysteine is a hydrophilic non-essential amino acid which can be synthesized
by humans from methionine. It is an aminothiol with three reactive centers: the amino
group, the carboxylic acid and the thiol group.

O
O

O
OH

S
HO

H2N
SH

DL-cysteine

OH

S

NH2

NH2

cystine

It contains sulfur in the form that can inactivate free radicals.183 Cysteine is implicated
in antioxidant defense mechanism against damaging species by increasing levels of the
most dominant antioxidant, glutathione. It is involved in protein synthesis and is the
precursor to the important aminosulfonic acid, taurine. The highly reactive thiol group,
which exists as the thiolate group at physiologic conditions, is an excellent scavenger
of reactive, damaging species. Cysteine also plays an important role in the metabolism
of a number of essential biochemicals including coenzyme A, heparin, biotin, lipoic
acid, and glutathione.184 While its nitrosation is facile185, there has not been, to date,
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an exhaustive kinetics study of its formation to the extent that this thesis is going to
present. The kinetics of its formation and decomposition will aid in evaluating if it
could be an effective carrier of NO by deducing, from the kinetics, its possible
lifetime.

4.1: Stoichiometry
The stoichiometry of the reaction subscribed to other known nitrosation
reactions in which one mole of HNO2 reacts with one mole of the thiol to form the
cysteine nitrosothiol with the elimination of a molecule of water.143
O
N
HO

S

O

NH2

S-nitrosocysteine

S-Nitrosocysteine, CYSNO, was not as stable as the known secondary and tertiary
nitrosothiols,118 but was stable at physiological and slightly basic environments for
several minutes. The lifetime was sufficient to allow for the determination of the
UV/Vis spectrum (see Figure 4.1, spectrum e). The spectrum shows that CYSNO has
an isolated absorption peak in the visible region at 544 nm. By running a series of
experiments in equimolar excess nitrite and acid over cysteine, it was possible to
evaluate an absorptivity coefficient of 17.2 ± 0.1 M-1 cm-1 for CySNO at 544 nm. This
was also confirmed by varying cysteine concentrations and testing the Lambert-Beer
law on the basis of expected product formation. CySNO had another peak at 335 nm
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with a much higher absorptivity coefficient of 736 M-1 cm-1; but at this peak, several
other species in the reaction medium such as nitrite and nitrous acid also contributed
considerably to the absorbance observed at 335 nm. Spectrum f was taken at very low
cysteine concentrations in order to produce CySNO which would give an absorbance
low enough at 335 nm to be measured on absorbance scale in Figure 4.1. All kinetics
measurements were performed at 544 nm.
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HNO2

1.0
d NO2-

e
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Figure 4.1: UV/vis spectral scan of reactants. (a), 0.04 M Cys, (b) 0.03 M NaNO2
(c) 0.04 M Cys + 0.03 M NaNO2 (d) 0.03 M NaNO2 + 0.05 M H+, (e) 0.04 M Cys +
0.03 M NaNO2 + 0.05 M H+ and (f) 0.004 M Cys + 0.003 M NaNO2 + 0.005 M H+
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4.2: Product determination
The relevant mass spectra for product determination are shown in Figure 4.2.
Within an hour of preparing CYSNO, QTOF mass spectra give a dominant m/z peak
at 150.87 (see Figure 4.2a) which would be the expected peak from CYSNO from the
positive mode electrospray technique utilized.

Figure 4.2: Mass spectrometry analysis of the product of nitrosation of Cys showing
(A) formation of CysNO, m/z = 150.87. (B) Product of decomposition of CysNO
after 24 hours, Cystine, a disulfide of Cys was produced with a strong peak, m/z =
241.00
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All other peaks observed in the spectrum are small and insignificant. Upon prolonged
standing, the peak at 150.87 disappeared while being replaced by a peak at 241.00
which is the expected peak for the cysteine disulfide, cystine. Figure 4.2b is a
spectrum of the products in Figure 4.2a after 24 hours. Over this period, the CYSNO
completely disappeared and the disulfide was quantitatively formed. Several previous
workers in this field had also concluded that the ultimate product in S-nitrosation is
the oxidation of the thiol to the disulfide.117,186,187

2RSNO → RSSR + 2NO

(R4.1)

There has been some debate as to veracity of reaction R4.1, with some schools of
thought suggesting that the reaction may be strongly influenced by oxygen
concentrations, or lack thereof.
In alkaline solutions, nitroalkanes deprotonate to give and aci-anion,
RCH=NO2-, which was recently discovered to be an excellent traps for NO, giving
signature-type EPR spectra which can be used as evidence for the presence of NO.142
Figure 4.3 shows a series of EPR spectra which prove the involvement of NO in
nitrosothiol chemistry. Pure trap, nitroethane, does not show any peaks without NO
(top spectrum), while nitrite with the trap will show no active peaks either (spectrum
B), as does cysteine on its own (spectrum C). The last three spectra show nitroethane
with varying concentrations of CySNO. The peaks derived from the interaction of the
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trap with NO increase with concentrations of CySNO showing that the decomposition
of CySNO involves release of NO.

2CysNO → CyS-SCy + 2NO

(R4.2)

A
B
C
D
E
F
G
3440

3450

3460

3470

3480

3490

Field/G

3500

3510

3520

3530

Figure 4.3: EPR spectra of NO radical generated during the decomposition of
CYSNO using 0.5 M nitroethane (NE) in 1.0 M NaOH solution as spin trap. (A) 0.5
M NE (B) 0.01 M NO2- (C) 0.04 M Cys; [CysNO] = (D) 0.02 M (E) 0.03 M (F)
0.04 M and (G) 0.05 M

98

4.3 Reaction Kinetics
Our study involved the simplest form of nitrosation: one that involves the in
situ production of the nitrosating agent, HNO2, in the same aqueous phase as the
reactants and products. More complex forms of nitrosation involve the availing of
gaseous nitric oxide through a nitric oxide-releasing compound. The biphasic nature
of these nitrosations renders the subsequent kinetics and mechanisms complex.
Through the use of the double-mixing feature of the stopped-flow ensemble, nitrous
acid was initially formed by the mixing of hydrochloric acid and sodium nitrite and
aged for about 1 sec before being combined with the thiol in a third feed syringe to
effect the nitrosation reaction. By assuming that protolytic reactions are fast, one can
assume that the protonation of nitrite as well as other subsequent reactions would have
reached equilibrium by the time the thiol is combined with the nitrosating agent. In
general the nitrosation kinetics were more reproducible when [H+]0 ≥ [NO2-]0.
Reliable kinetics data used to evaluate rate constants utilized data in which acid
concentrations were equal or slightly greater than nitrite concentrations.

4.3.1

Effect of cysteine concentrations

For the evaluation of the effect of cysteine on the rate of nitrosation, equimolar
concentrations of acid and nitrite were used. The final active concentrations of nitrite
and acid at the beginning of the reaction were constant and could easily be evaluated
from the acid dissociation constant of nitrous acid. Figure 4.4a shows the absorbance
traces obtained from a variation of initial cysteine concentrations. There was a linear
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and monotonic increase in the final CYSNO formed for as long as cysteine remained
as the limiting reagent, which was the case for all the traces shown in Figure 4.4a.
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Figure 4.4a: Absorbance traces showing the effect of varying Cys concentrations.
The reaction shows first-order kinetics in Cys. [NO2-]0 = 0.10 M; [H+]0 =0.10 M;
[Cys]0 = (a) 0.01 M, (b) 0.02 M, (c) 0.03 M, (d) 0.04 M, (e) 0.05 M, (f) 0.06 M and
(g) 0.07 M.

Figure 4.4b shows that the effect of cysteine is linear, with a first order dependence.
There was a noticeable saturation in cysteine’s effect on the initial rate of formation of
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CysNO at higher initial cysteine concentrations. Lower concentrations, however, gave
a linear dependence with an intercept kinetically indistinguishable from zero as would
have been expected in a system in which all cysteine is quantitatively converted to the
nitrosothiol.
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Figure 4.4b: Initial rate plot of the data in Figure 4.4a. The plot shows strong
dependence on initial rate of formation of CysNO on Cys.
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4.3.2 Effect of nitrite
Figure 4.5a showed surprisingly simple and reproducible kinetics upon variation of
nitrite. Data in Figure 4.5a were derived from varying nitrite in regions where acid
concentrations are in excess. A combination of data involving the variation of initial
concentrations from below initial acid concentrations to being above the acid
concentrations did not retain linearity through the whole range of the plot because of
the varying concentrations of HNO2 formed that are nonlinearly dependent on the
initial nitrite concentrations.
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Figure 4.5a: Absorbance traces showing the effect of varying nitrite concentrations.
The reaction shows first-order kinetics in nitrite. [Cys]0 = 0.10 M; [H+]0 = 0.10 M;
[NO2-]0 = (a) 0.01 M, (b) 0.02 M, (c) 0.03 M, (d) 0.04 M, (e) 0.05 M, (f) 0.06 M and
(g) 0.07 M.
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With the conditions utilized for Figures 4.5a and b; the changes in nitrosating agent,
HNO2, were clearly linearly dependent on the initial nitrite concentrations. Thus the
linear dependence on initial rate of formation of CysNO with nitrite concentrations
shown in Figure 4.5b was expected.
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Figure 4.5b: Initial rate plot of the data in Figure 4.5a. The plot shows strong
dependence on initial rate of formation of CysNO on nitrite.
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4.3.3: Effect of acid
The effect of acid, as expected, was more complex (see Figure 4.6a). The data in
Figure 4.6a involves changes in acid concentrations that spanned initial acid
concentrations below nitrite concentrations to those in high excess over nitrite. The
initial acid concentrations in Figure 4.6a were increased step-wise by 1.00 x 10-2 M;
but the final acid concentrations in the reaction mixtures did not increase by the same
constant rate due to the dissociation equilibrium of HNO2.
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Figure 4.6a: Effect of low to high acid concentrations on the formation of CysNO.
[Cys]0 = 0.05 M; [NO2-]0 = 0.05 M; [H+]0 = (a) 0.01 M, (b) 0.02 M, (c) 0.04 M, (d)
0.05 M, (e) 0.06 M, (f) 0.07 M, (g) 0.08 M, (h) 0.09 M, (j) 0.10 M, (k) 0.11 M, (l) 0.12
M and (m) 0.13 M.
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Thus a new table was created in which the final initial acid concentrations as well as
nitrous acid and nitrite concentrations were calculated (see Table 4.1). These were the
concentration values utilized in the acid dependence plot shown in Figure 4.6b.
Available acid concentrations are heavily depressed in conditions in which the initial
nitrite concentrations exceed the initial acid concentrations (first 4 data points in plot
Figure 4.6b).
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Figure 4.6b: Initial rate plot of the data in Figure 4.6a showing first-order
dependence of the rate of formation of CysNO on acid at high acid concentrations.
NO+ is the main nitrosating agent.
The next series of data points involve conditions in which the added acid
concentrations exceed nitrite. The resulting final free acid concentrations are derived
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from the excess acid plus the acid derived from the dissociation of nitrous acid. This
dissociation is heavily depressed by the initial presence of excess acid, and thus there
is a roughly linear relationship between the added acid and the final acid
concentrations obtaining at the start of the reaction.

Table 4.1: Calculations (in mol L-1) of the final reactive species for acid dependence
data shown in Figures 6a, b.

[H+]added

[NO2-]added

[HNO2]0

[NO2-]0

[H+]0

0.01

0.05

9.88 x 10-3

4.01 x 10-2

1.12 x 10-4

0.02

0.05

1.97 x 10-2

3.03 x 10-2

2.99 x 10-4

0.03

0.05

2.94 x 10-2

2.07 x 10-2

6.54 x 10-4

0.04

0.05

3.85 x 10-2

1.15 x 10-2

1.53 x 10-3

0.05

0.05

4.54 x 10-2

4.59 x 10-3

4.59 x 10-3

0.06

0.05

4.81 x 10-2

1.87 x 10-3

1.19 x 10-2

0.07

0.05

4.89 x 10-2

1.07 x 10-3

2.11 x 10-2

0.08

0.05

4.93 x 10-2

7.37 x 10-4

3.07 x 10-2

0.09

0.05

4.94 x 10-2

5.60 x 10-4

4.06 x 10-2

0.10

0.05

4.96 x 10-2

4.50 x 10-4

5.05 x 10-2

0.11

0.05

4.96 x 10-2

3.80 x 10-4

6.04 x 10-2

0.12

0.05

4.97 x 10-2

3.30 x 10-3

7.03 x 10-2

0.13

0.05

4.97 x 10-2

2.90 x 10-3

8.03 x 10-2
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Table 4.1 shows that when acid exceeds nitrite concentrations ([H+]0 > 0.05 M), the
final acid concentrations are directly proportional to the initial added acid
concentrations and that nitrous acid concentrations remain nearly constant in this
range while asymptotically approaching 0.05 M. Since initial nitrite concentrations
were constant, the constant concentrations of HNO2 in this range are expected and the
effect of acid can thus be isolated. The linear plot observed for the effect of acid in
this range suggests first order kinetics in acid for the nitrosation reaction (see Figure
4.6c).
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Figure 4.6c: Effect of acid on nitrosation in the high acid range. The intercept
value should give an estimate of the nitrosation effect of nitrous acid without excess
acid.
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It is also important to note that in the first four data points in Figure 4.6b, there is a
wild variation in both acid and the nitrosating agent, HNO2 (see Table 4.1). The
discontinuity in acid effect occurs when initial acid concentrations exceed initial nitrite
concentrations, and final nitrite concentrations after acid equilibrium has been effected
become negligible. Table 4.1 can be used to evaluate the effects of each of the
relevant species in solution towards nitrosation. This is shown in Figure 4.6d.
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Figure 4.6d: An evaluation of the effects of nitrite, nitrous acid and excess acid on
the rate of nitrosation. Plot shows that nitrite is not involved in nitrosation, and that
after the saturation of nitrous acid concentrations, a new nitrosant emerges, whose
formation is catalyzed by acid.
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In this figure, rate of nitrosation is plotted against nitrite, nitrous acid and acid
concentrations. Increase in nitrous acid concentrations catalyze nitrosation up to 0.05
M (its maximum), but the fact that rate of nitrosation keeps increasing despite static
nitrous acid concentrations implies the presence of another nitrosant. Though
nitrosation rate is discontinuous in acid concentrations, there is, generally, a
monotonic catalysis of nitrosation by acid.

4.3.4: Effect of Cu2+ ions
The established experimental data implicates Cu+ ions in the catalysis of
decomposition of nitrosothiols. However, Figure 4.7a shows that Cu(II) ions are
extremely effective catalysts in the formation of CysNO when they are in the
millimolar concentration ranges and even lower. A plot to quantitatively evaluate the
effect of Cu(II) ions is shown on Figure 4.7b. It shows the typical catalyst effect that
shows an ever-increasing rate with Cu(II) followed by a saturation. The micromolar
Cu(II) concentration ranges are shown in Figure 4.7c. Figure 4.7c involves a longer
observation time that encompasses both the formation and the consumption of CysNO.
This figure shows that, even though Cu(II) ions catalyze the formation of CysNO, they
also catalyze its decomposition. Thus, in the presence of Cu(II) ions, the maximum
expected quantitative formation of CYSNO is not observed since the onset of
decomposition of CYSNO is strongly enhanced in the presence of Cu(II) ions.
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Figure 4.7a: Absorbance traces showing the effect of varying Cu2+ concentrations
on the rate of formation of CysNO in the absence of perchloric acid. There is a
progressive increase in the rate of CysNO formation with increase in Cu2+
concentration. [Cys]0 = [NO2-]0 = 0.05; [H+]0 = 0.00 M; [Cu2+]0 = (a) 0.001 M, (b)
0.0015 M, (c) 0.002 M, (d) 0.0025 M, (e) 0.003 M, (f) 0.0035 M, (g) 0.004 M, (h)
0.0045 M and (j) 0.005 M
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Figure 4.7b: Initial rate plot of the data in Figure 4.7a showing the catalytic effect
of copper.
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Figure 4.7c: Absorbance traces showing the effect of varying Cu2+ concentrations
on the rate of formation of CysNO in the presence of perchloric acid. There is a
progressive increase in the rate of CyNO formation with increase in Cu2+
concentration. High Cu2+ concentrations give an early onset of the decomposition of
CysNO. [Cys]0 = [NO2-]0 = [H+]0 = 0.01 M; [Cu2+]0 = (a) 0.00 M , (b) 1.0 µM, (c) 2.5
µM, (d) 5.0 µM, (e) 10.0 µM, (f) 50.0 µM and (g) 100.0 µM.

4.3.5: Decomposition of CYSNO
The lifetime of CysNO in the physiological environment is determined by its rate of
decomposition, especially at physiological pH conditions. Figure 4.8 shows the
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decomposition kinetics of CysNO. Decompositions of nitrosothiols are metal-ion
mediated. Trace a shows the slow decomposition of CysNO using normal reagent
water and without chelators to sequester metal ions (mostly 0.43 ppb of Pb2+
according to ICPMS analysis). Trace b shows the same solution in trace a, but this
time with EDTA added to sequester any metal ions.
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Figure 4.8: Effect of Cu2+ on the stability of CysNO in a pH 7.4 phosphate buffer.
[CysNO]0 = 0.01 M; [Cu2+]0 = (a) 0.00 M , (b) 0.00 M Cu2+ + 10 µM EDTA), (c) 5
µM, (d) 10 µM, (e) 20 µM, (f) 30 µM, (g) 40 µM and (h) 50 µM.
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This shows that the decomposition of CysNO becomes even slower under these
conditions; proving that even the very low metal ion concentrations present in reagent
water are effective in catalyzing CySNO’s decomposition. The rest of the traces show
ever-increasing concentrations of Cu2+ ions, but still in the micromolar range. There is
noticeable autocatalysis in the rate of decomposition of CySNO.

4.4: MECHANISM.
Experimental data suggests a very simple nitrosation kinetics scheme that is first order
in thiol and nitrite and slightly more complex dependence on acid. The acid effect has
to be derived from its effect on the possible nitrosating agents. There are five possible
nitrosating agents: HNO2, N2O3, NO2, NO and NO+. Pure nitric oxide itself, NO, is
highly unlikely to be a nitrosating agent in this environment because no thiyl radicals
were observed using the DMPO spin trap during the entire lifetime of the reaction.
Nitric oxide was observed only as a decomposition product (see Figure 4.3). NO2 and
N2O3 are both derived from the autoxidation of nitric oxide.188
NO + ½O2

NO2

NO + NO2 → N2O3

(R4.3)
(R4.4)

N2O3 and NO+ are the strongest nitrosating agents out of the five possibilities189
Formation of NO2 is dependent on the dissolved oxygen in solution, which is normally
at approximately 2.0 x 10-4 M. NO concentrations are expected to be in the fractions
of millimolar in concentrations. Thus, both reactions R4.3 and R4.4 will not be
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effective in producing significant nitrosating agents. The elimination of three
nitrosating agents leaves HNO2 and NO+, the nitrosonium cation190 as the predominant
nitrosants. These two nitrosants both support first order kinetics in nitrite and thiol.

H+ + NO2HNO2 + H+

HNO2

k4, k-4; Ka-1

(R4.5)

+

N=O + H2O k5, k-5

CysH + HNO2 →

CysNO + H2O

CysH + +N=O

CysNO + H+ k7, k-7

(R4.6)
k6

(R4.7)
(R4.8)

Addition of reaction R4.6 is supported by the acid effect on the reaction which show a
strong acid dependence even when [H+]0 > [NO2-]0. Without reaction R4.6, a quick
saturation in acid effect should be observed when acid concentrations exceed nitrite
concentrations since further increase in acid concentrations should leave concentration
of the single nitrosant, HNO2 invariant. It is highly unlikely that the nitrosonium
cation exists as the naked form in aqueous media, and one would expect it to be
hydrated, HN+OOH. Other lab groups represent it as the protonated nitrous acid;
H2ONO+. From the use of these two dominant nitrosants; one can derive an initial
rate of reaction:

k5 k7 [H + ]
d [CysNO ] [CysH ][ N ( III )]T [ H + ]
Rate =
=
(k 6 +
)
dt
k −5 + k 7 [CysH ]
K a + [H + ]

(1)

Where
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N(III)]T = [NO2-] + [HNO2] + [RSNO] + [+N=O]

(2)

Derivation of (1) from (2) was simplified by assuming that at the beginning of the
reaction, concentrations of both the thiol and the nitrosonium ion are vanishingly
small. Equation (1) can be further simplified by assuming that the forward and reverse
rate constants for Reaction R4.6 are rapid enough such that the term k7[CySH] in the
denominator can be discarded, giving:

d [ RSNO ] [CySH ][ N ( III )]T [ H + ]
=
(k 6 + K 5 k 7 [H + ])
+
dt
K a + [H ]

(3)

Where K5 is the equilibrium constant for the formation of the nitrosonium ion. Both
equations (1) and (3) are versatile enough to support all the observed kinetics behavior
of the system. This supports the observed first order kinetics in thiol and in nitrite
concentrations (Figures 4.4 and 4.5), and also supports the observed bifurcation in acid
effects shown in Figure 4.6b. These equations do not support second order kinetics in
acid, despite the possible dominance of reaction R4.6 in highly acidic environments
where the tandem of protonation of nitrite (R4.5) and the further protonation of HNO2
(R4.6) will be a prerequisite for the formation of the nitrosant, culminating with
second order kinetics. At low acid, the second term in (1) (and in (2) as well vanishes,
and if low enough, where Ka >> [H3O+]; first order kinetics would result. With such a
low value of Ka; in general Ka = [H3O+]; and acid behavior would display the curving
observed in the low acid concentration range of Figure 4.6b. In high acid
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concentrations, where initial acid concentrations strongly exceed the dissociation
constant of nitrous acid, the second term will display first order kinetics while the first
term will be kinetically silent with respect to acid. The first order dependence in acid
observed in the high acid region of Figure 4.6b confirms the mathematical form of
Equation 2.
An evaluation of bimolecular rate constant k6 can be made from the data
shown in Figures 4.4a and b. In this set of data, [H+]0 = [NO2-]0 = 0.10 M such that
the final acid concentration at the beginning of the reaction are determined by the
dissociation constant of 0.10 M HNO2. The millimolar concentration of acid present
nullify the second term in equation (3), and the slope of the thiol dependence plot can
be equated to [N(III)]T[H3O+]0/(Ka + [H3O+]0. These values will remain essentially
constant for the range of the thiol concentrations used for this plot (figure 4.4b). Since
the prevailing pH for these experiments is below the isoelectronic point of cysteine, it
is reasonable to assume that a variation in thiol concentrations should not alter,
significantly, the final acid concentrations. This evaluation gives k6 = 6.4 M-1 s-1.
The linear part of Figure 4.6b can allow for the evaluation of the second
bimolecular rate constant, k7. Both first and second terms in Equation (3) contribute to
the overall rate of reaction, but any increase in rate with acid is solely on the basis of
the second term since the first term saturates with respect to acid as the nitrous
concentrations become invariant to further increases in acid. The intercept of Figure
4.6b should enable for the calculation of k6. The value of the intercept was 1.06 x 10-2
M s-1 and this was equated to k6[CySH]0[N(III)]T to evaluate k6 = 6.4 M-1 s-1. This
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was the exact same value derived from thiol dependence experiments shown in Figure
4.4b. The congruence of these values for k6; while derived from two separate
approaches, proves the general veracity of the simple proposed mechanism. The slope
can only enable for the evaluation of K5k7; and without an independent evaluation of
K5, it is not possible to evaluate an unambiguous value for k6. From the rapid increase
in nitrosation rate in response to acid increase after saturation of HNO2, it appears that
k7 >> k6. The value of K5 is heavily-dependent on the pH and ionic strength of the
reaction medium, and any value adopted for this study will be on the basis of how best
this value can support the proposed equilibrium. By utilizing a previously-derived
value of K5 = 1.2 x 10-8 M-1; k7 was evaluated as 2.89 x 1010 M-1 s-1 (no error bars
could be calculated for this value).

Effect of Copper.
Cu+ is well known to be an efficient catalyst for nitrosothiol decompositions by
preferentially bonding the S center over the N center of the nitrosothiol.162 This
preferential binding, which in the model compound HSN=O has been evaluated at
39.6 kJ in favor of the S-binding; lengthens the S-N bond and facilitates its
cleavage.191 Thus addition of Cu+ ions to reactions involving the formation of
nitrosothiols would show a progressive decrease in the yields of nitrosothiols with
increasing additions of micromolar quantities of Cu+ ions up to a saturation. The
interpretation of the effect of Cu2+ is a little more involved. Figures 4.7a and b clearly
show that Cu2+ ions are catalytic in the formation of nitrosothiols. Figure 4.7b also
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shows the faintly sigmoidal increase in rate followed by a sharp saturation, which is a
hallmark of most catalysis reaction dynamics. The general school of thought is that
Cu2+ ions, in themselves are innocuous in this environment, but that, in the presence of
micromolar quantities of thiolate anions, redox-cycling would occur between Cu2+ and
Cu+; thereby effecting the catalysis.

2CyS- + 2Cu2+ → CySSCy (dimer) + 2Cu+
2CySNO + 2Cu+ → 2CyS- + 2Cu2+

(R4.9)
(R4.10)

Data in Figures 4.7a and b were run in the absence of acid to encourage the formation
of the thiolate anions. Recent experimental data has shown that this effect of
establishing redox cycling is not a preserve of thiolate anions exclusively, but any
effective nucleophile in reaction medium such as ascorbate anions, halogens and
pseudohalogens can bring about the sequence of reactions R4.9 and R4.10.26,83,192 In
the absence of acid, Cu2+ catalyzes formation of the nitrosothiol, but on observing the
long term effect of Cu2+ ions (Figure 4.7c), one notices that even though Cu2+ catalyze
formation of the nitrosothiol, they also catalyze the decomposition of the nitrosothiol.
Higher concentrations of copper ions rapidly form the nitrosothiol, and also encourage
a rapid onset of decomposition.
Figure 4.8 attempts to simulate the physiological environment by using a
phosphate buffer at pH 7.4. The nitrosocysteine was initially prepared and then
combined with the various reagents shown in that figure to evaluate the decomposition
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kinetics of CySNO. The first two traces are displayed to show that there are negligible
metal ions in the distilled water utilized in our laboratories. The solution run with a
metal ion sequester displays very similar kinetics to the one without EDTA. The
ambient pH is above the isoelectronic point of cysteine, and thus will encourage
formation of thiolate anions. The observed autocatalysis can be explained in a similar
manner. Decomposition of CySNO will form the dimer, CySSCy, which can form
more thiolate anions. Higher thiolate concentrations should increase the turn-over
number of the catalyst. Work by Francisco et al showed the same autocatalysis in the
decomposition and further reaction of formamidine disulfide with nitric oxide which
they explained through the formation of a pseudohalogen, SCN-, which forms
NOSCN.193

4.5: CONCLUSION
The mechanism of nitrosation, though simple, differs with thiols and with reaction
conditions, especially pH. In this study, the two major nitrosants are nitrous acid itself
and the nitrosonium ion which is formed from the further protonation of the weak
nitrous acid. There was no strong evidence to evoke the possibility of N2O3 as a
contributing nitrosant at low pH. Its exclusion still gave a kinetics rate law that was
strongly supported by the experimental data. Cysteine nitrosothiol does not seem to
have a long enough half life in the physiological environment to enable it to be an NO
carrier. The general school of thought is that since the EDRF can be linked with
NO,4,100 then NO’s interaction with protein thiol residues should be the process by
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which it expresses its physiological activity. The most abundant thiol in the
physiological environment is glutathione, and maybe its nitrosothiol may be more
robust in the human body, thus making it the most likely candidate for the transport of
NO. This thesis has proved that the nitrosothiol from cysteine is not that stable,
decompositing completely in the presence of micromolar quantities of copper within
100 seconds. With the large numbers of metal ions and metalloenzymes in the
physiological environment, one expects the lifetime of a cysteine nitrosothiol to be
even shorter.
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CHAPTER 5
KINETICS AND MECHANISMS OF MODULATION OF HOMOCYSTEINE
TOXICITY BY S-NITROSOTHIOL FORMATION
5.0 INTRODUCTION
Homocysteine, HCYSH, is a non-protein forming biologically active
organosulfur amino acid. It is primarily produced by the demethylation of the
essential, protein forming amino acid methionine. Under normal conditions, the total
plasma concentration of HCYSH usually ranges from 5 to 15 µmol/L. A higher fasting
level is described as hyperhomocysteinemia which is further categorized into
moderate and severe hyperhomocysteinemia for the HCYSH levels in the range 16 to
100 µmol/L and >100 µmol/L respectively.194-196 Research over the decades has
established that hyperhomocysteinemia, is a risk factor in a variety of disease states
including cardiovascular, neurodegenerative and neural defects.197-200
Hyperhomocysteinemia is believed to arise from abnormal metabolism of methionine
particularly in diet with deficiency of B-vitamins such as folate, vitamin B-12 and/or
vitamin B-6.201 In the human body methionine is used for the synthesis of a universal
methyl donor S-adenosylmethionine (AdoMet).202 Upon donation of its methyl group,
AdoMet is converted to S-adenosylhomocysteine (AdoHcy) which subsequently
hydrolyzed to HCYSH and adenosine.202,203 In the physiological environment,
HCYSH levels are regulated by remethylation to methionine by the enzyme
methionine synthase in the presence of vitamin B-12 and 5,10-methyltetrahydrofolate,
and by trans-sulfuration to cystathionine by the enzyme cystathionine β-synthase and
vitamin B-6 as co-factor.197,203
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It has become evident that an impairment to remethylation and transsulfuration metabolic pathways of HCYSH results in an alternative metabolic
conversion of HCYSH to a chemically reactive homocysteine thiolactone (HTL).203
Formation of this cyclic thioester HTL is believed to be one of the major factors
responsible for the pathogenesis of HCYSH.204 HTL is a highly reactive metabolite
that causes N-homocysteinylation of proteins leading to the modification of their
structural and physiological functions.205 This means that any process that can prevent
the oxidation of HCYSH to HTL will alleviates the toxicity of HCYSH. One of such
processes is the S-nitrosation of HCYSH to form S-nitrosohomocysteine (HCYSNO).
Unlike HCYSH, HCYSNO does not support ring closure that may lead to the
formation of HTL.206 It is therefore plausible to assume that HCYSH toxicity could
occur when there is an imbalance between the available nitrosating agents such as
nitric oxide (NO) and the HCYSH levels in the body.
S-nitrosohomocysteine has been found in human plasma and has been shown
by Glow and co-workers to be an important mediator of vasorelaxation.207 Although
some authors have suggested the inhibition of S-center of HCYSH via the formation
of S-nitrosothiols,206-210 the mechanism of reactions of NO and NO-derived nitrosating
agents with HCYSH to form HCYSNO has however not been clearly elucidated. We
therefore report in this doctorate thesis on the kinetics and mechanisms of nitrosation
of HCYSH by physiologically active nitrosating agents.
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5.1 RESULTS
The progress of the nitrosation reaction was monitored spectrophotometrically
by following absorbance of S-nitrosohomocysteine (HCYSNO) at its experimentally
determined absorption peak of 545 nm where an absorptivity coefficient of 20.2 ± 0.2
M-1cm-1 was evaluated. Although HCYSNO has a second absorption peak at 331 nm,
with a much higher absorptivity coefficient (1040.00 ± 3.00 M-1cm-1), its maximum
absorption at 545 nm was used due to lack of interference from the absorption peaks
of nitrogen species NO2-, NO+ and HNO2 at this absorption wavelength ( see Figure
5.1).
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Figure 5.1: UV/vis spectral scan of reactants and product. (a), 0.005 M HCYSH, (b)
0.005 M NaNO2 (c) 0.005 M HNO2, (d) 0.005 M HCYSNO and (e) 0.0025 M
HCYSNO.
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5.1.1 Stoichiometry determination
The stoichiometry of reaction between HNO2 and HCYSH was determined as:

HNO2 + H2NCH(COOH)CH2CH2SH → H2NCH(COOH)CH2CH2SNO + H2O (R5.1)

Reactions run for the deduction of this stoichiometry were performed by varying the
amount of HNO2 while keeping the amount of HCYSH constant. HNO2 was generated
by mixing equimolar amounts of perchloric acid and sodium nitrite. The reaction was
allowed to proceed to completion while rapidly scanning the reacting solution between
400 nm and 700 nm. The concentration of the product HCYSNO was deduced from its
maximum absorption at 545 nm. This stoichiometry is the highest HNO2/HCYSH
ratio that produced the maximum amount of HCYSNO. No nitrosation reaction at the
N-center of homocysteine was observed. All nitrosation occur at the S-center because
it is more nucleophilic than the 2˚ N-center.

5.1.2 Product identification:
Mass spectrometry was used to conclusively identify the products of the
nitrosation reactions. Figure 5.2, spectrum A is from pure DL-homocysteine.
Spectrum B, from the product of the reaction, shows a HCYSNO m/z peak at 136.00
which is the expected peak from the positive mode of the electronspray ionization
mass spectrometry technique used for this analysis.
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The production of NO from the decomposition of HCYSNO (R5.2) was
detected by EPR techniques through the use of aci anion of nitroethane as a spin
trap.211

Figure 5.2: Mass spectrometry analysis of the product of nitrosation of HCYSH
showing (A) pure HCYSH m/z 136.00 and (B) formation of HCYSNO, m/z = 164.87.
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In alkaline environments nitroethane (CH3CH2NO2) forms an aci anion (R5.3) which
can effectively scavenge NO to form a long-lived NO-adduct (R5.4).

HCYSNO → HCYSSHCY + NO

(R5.2)

CH3CH2NO2 + OH- → CH3CH=NO2- + H2O

(R5.3)

CH3CH=NO2- + NO + OH- → [CH3C(NO)(NO2)]˙2- + H2O

(R5.4)

A
B

C

D

3440

3450

3460

3470

3480

[G]

3490

3500

3510

3520

3530

Figure 5.3: EPR spectra of NO radical generated during the decomposition of
HCYSNO using 0.5 M nitroethane (NE) in 1.0 M NaOH solution as spin trap. (A)
0.5 M NE (B) 0.03 M HCYSNO (C) 0.05 M HCYSNO (D) 0.03 M HCYSNO +
2.0 x 10-4 M Cu2+.
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Direct detection of NO without a spin trap is difficult due to its broad ESR
spectrum.141 Figure 5.3 shows a series of ESR spectra that confirm the production of
NO from the decomposition of HCYSNO. The splitting constant is consistent with
that expected for a typical aci-nitroethane-NO adduct. All spectra were scaled on the
same X-Y coordinate range and run under the same conditions. Spectrum A shows
that aci nitroethane on its own does not show any peaks in the absence of NO. Spectra
B and C show nitroethane with varying concentrations of HCYSNO in which the peak
height increases with increase in HCYSNO concentrations. Spectrum D has equal
concentrations of HCYSNO as in spectrum B but with the addition of copper. It
clearly demonstrates the catalytic effect of copper in effecting NO release from Snitrosothiols. More NO is released in D than in B within the same reaction time as
reflected by the peak height, which is directly proportional to the amount of NO.

5.1.3 Reaction Dynamics
The reaction essentially involved the S-nitrosation of HCYSH by nitrous acid,
which is generated in situ by mixing perchloric acid and sodium nitrite using the
double mixing mode of the Hi-Tech Scientific SF61-DX2 stopped-flow
spectrophotometer. It is necessary to generate the nitrous acid in situ due to its
instability to disproportionation reaction (R5.5).

3HNO2 → H+ + NO3- + 2NO + H2O

(R5.5)
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Unlike S-nitrosothiols of most of the primary aminothiols such as cysteine, HCYSNO
is surprisingly stable at physiological pH of 7.4. Its half-life was determined to be 198
hours in the absence of reducing agents such as transition metal ions and thiols, which
could catalyze its decomposition.

HCYSH dependence: The rate of formation of HCYSNO from the reaction of
HCYSH and HNO2 is significantly dependent on the initial concentration of HCYSH.
As long as HCYSH is the limiting reactant, the rate of nitrosation and the amount of
HCYSNO formed increases with increase in the initial concentration of HCYSH
(Figure 5.4a). The reaction shows a first order dependence in HCYSH with an
intercept kinetically indistinguishable from zero (Figure 5.4b).

Nitrite and acid dependence: Change in the initial concentrations of both nitrite and
acid (perchloric acid) have a great effect on the dynamics of the reaction. As starting
concentration of nitrite increases in excess acid and HCYSH, final concentration of
HCYSNO formed linearly increases as seen in traces a-g of Figure 5.5a. Initial rate
plot of these kinetics traces displayed a typical first-order dependence on nitrite for a
nitrosation reaction in excess acid (Figure 5.5b).
Acid, as expected, exerts a most powerful effect on the rate of formation of
HCYSNO. Figure 5.6a shows a series of kinetics experiments in which the
concentration of acid is varied from 0.005 – 0.100 mol/L. The concentrations of both
nitrite and HCYSH for these experiments were constant and fixed at 0.05 M.
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Figure 5.4a: Absorbance traces showing the effect of varying HCYSH
concentrations. The reaction shows first-order kinetics in HCYSH. [NO2-]0 = 0.05
M; [H+]0 =0.05 M; [HCYSH]0 = (a) 0.005 M, (b) 0.006 M, (c) 0.007 M, (d) 0.008 M,
(e) 0.009 M, (f) 0.010 M and (g) 0.011 M.
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Figure 5.4b: Initial rate plot of the data in Figure 5.4a. The plot shows strong
dependence on initial rate of formation of HCYSNO on HCYSH.
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Figure 5.5a: Absorbance traces showing the effect of varying nitrite concentrations.
The reaction shows first-order kinetics in nitrite. [HCYSH]0 = 0.05 M; [H+]0 = 0.05
M; [NO2-]0 = (a) 0.005 M, (b) 0.006 M, (c) 0.007 M, (d) 0.008 M, (e) 0.009 M, (f)
0.010 M and (g) 0.011 M.
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Figure 5.5b: Initial rate plot of the data in Figure 5.5a. The plot shows strong
dependence on initial rate of formation of HCYSNO on nitrite.

Since the nitrosation experiments essentially involve reaction of nitrous acid with
HCYSH, a table was created in which the final concentrations of nitrous acid were
calculated (Table 5.1). The amount of HCYSNO formed increases as concentration of
acid increases until the concentration of the final nitrous acid is approximately equal to
the concentration of HCYSH and saturation is attaine as shown in traces h-k in Figure
5.6a.
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Figure 5.6a: Absorbance traces showing the effect of varying acid concentrations.
[HCYSH]0 = 0.05 M; [NO2-]0 = 0.05 M; [H+]0 = (a) 0.005 M, (b) 0.01 M, (c) 0.02 M,
(d) 0.03 M, (e) 0.04 M, (f) 0.05 M, (g) 0.06 M, (h) 0.07 M, (i) 0.08 M, (j) 0.09 M and
(k) 0.10 M.

The initial rate plot with respect to the final concentrations of HNO2 showed a firstorder linear plot in the region where the initial concentrations of acid exceeded the
nitrite concentration (Figure 5.6b) and a non-linear quadratic second-order kinetics in
the region where the final concentrations of HNO2 were less than the initial nitrite
concentration (Figure 5.6c).
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Figure 5.6b: Plot of initial rate versus nitrous acid concentrations of the
experimental data in Figure 5.6a (traces h-k) and calculated in Table 1 at pH < 2.
The plot shows a first-order dependence on the initial rate of formation of HCYSNO
on the final nitrous acid concentrations.

Confirmatory evidence for the observed second-order kinetics in excess nitrite was
obtained by plotting the initial rates against the squares of the final nitrous acid
concentrations. A linear plot was obtained with an almost zero intercept (Figure 5.6d).
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Figure 5.6c: Plot of initial rate versus nitrous acid concentrations of the
experimental data in Figure 5.6a and calculated in Table 1 at pH 2 and above. The
curve fit well into a polynomial of degree two, which is an indication of rate being
dependent on the square of the final nitrous acid concentrations.

In order to further establish this observed transition from second-order kinetics to firstorder kinetics as the initial concentrations of acid increase from less than to more than
the initial nitrite concentrations, a new series of HNO2-dependence experiments were
performed at two fixed pHs 1.2 and 4.0 for two different HCYSH concentrations
(Figure 5.7a and 5.7c). The experiments were done under the same conditions. In
perfect agreement with our earlier observation, plots of initial rates vs [HNO2] for data
at pH 1.2 gave linear plots expected for first-order kinetics (Figure 5.7b). Also, plots
of initial rates vs [HNO2] for data at pH 4.0 gave a non-linear quadratic curve
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expected for second-order kinetics (Figure 5.7d).

Table 5.1: Input species concentrations and final reagent concentrations for acid
dependence experiments.
[H+]added

[NO2-]added

[HNO2]initial

[NO2-]final

[HNO2]final

[H3O+]final

(mol/L)

(mol/L)

(mol/L)

(mol/L)

(mol/L)

(mol/L)

~ pH

0.005

0.05

0.005

4.51 x 10-2

4.94 x 10-3

6.16 x 10-5

4.21

0.01

0.05

0.01

4.01 x 10-2

9.86 x 10-3

1.38 x 10-4

3.86

0.02

0.05

0.02

3.04 x 10-2

1.97 x 10-2

3.63 x 10-4

3.44

0.03

0.05

0.03

2.92 x 10-2

7.90 x 10-4

3.10

0.04

0.05

0.04

3.82 x 10-2

1.82 x 10-3

2.74

0.05

0.05

0.05

4.50 x 10-2

5.03 x 10-3

2.30

0.06

0.05

0.05

4.78 x 10-2

1.22 x 10-2

1.91

0.07

0.05

0.05

4.87 x 10-2

2.13 x 10-2

1.67

0.08

0.05

0.05

8.93 x 10-4

4.91 x 10-2

3.09 x 10-2

1.51

0.09

0.05

0.05

6.81 x 10-4

4.93 x 10-2

4.07 x 10-2

1.39

0.10

0.05

0.05

5.50 x 10-4

4.95 x 10-2

5.06 x 10-2

1.30

2.08 x 10-2

1.18 x 10-2
5.03 x 10-3

2.22 x 10-3
1.29 x 10-3
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Figure 5.6d: Plot of initial rate versus square of the final nitrous acid
concentrations. This plot shows a second order dependence in nitrous acid at pH 2
and above.
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Figure 5.7a: Absorbance traces showing the effect of varying nitrous acid
concentrations at pH 1.2 in phosphate buffer. [HCYSH]0 = 0.05 M; [NO2-]0 = [H+]0
= (a) 0.005 M, (b) 0.01 M, (c) 0.015 M, (d) 0.02 M, (e) 0.025 M, (f) 0.03 M, (g) 0.035
M, (h) 0.04 M, (i) 0.045 M and (j) 0.05 M
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Figure 5.7b: Combined HNO2 dependence plots at 0.05 M HCYSH (of the data in
Figure 3.7a) and 0.09 M HCYSH showing first-order linear dependence of the rate
of formation of HCYSNO on HNO2 at pH 1.2. These data were utilized in equation
8 for the evaluation of k6.
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Figure 5.7c: Absorbance traces showing the effect of varying nitrous acid
concentrations at pH 4.0 in phosphate buffer. [HCYSH]0 = 0.05 M; [NO2-]0 = [H+]0
= (a) 0.005 M, (b) 0.01 M, (c) 0.015 M, (d) 0.02 M, (e) 0.025 M, (f) 0.03 M, (g) 0.035
M, (h) 0.04 M, (i) 0.045 M and (j) 0.05 M.

141

0.003
[HCYSH]0 = 0.09 M

0.0025

Initial rate/Ms-1

0.002

0.0015
[HCYSH]0 = 0.05 M

0.001

0.0005

0
0

0.005

0.01

0.015

0.02

0.025

0.03

0.035

0.04

[HNO2]/M

Figure 5.7d: Combined HNO2 dependence plots at 0.05 M HCYSH (of the data in
Figure 5.7c) and 0.09 M HCYSH showing non-linear quadratic dependence of the
rate of formation of HCYSNO on HNO2 at pH 4.0. These data were utilized in
equation 9 for the evaluation of k4 and k5.

Catalytic effect of Copper: Copper is an essential trace element that is indispensable
for normal growth and development. It serves as a cofactor for the activity of a
number of physiologically important enzymes such as methionine synthase, which
plays a key role in the synthesis of methionine from homocysteine, and extracellular
and cytosolic Cu-dependent superoxide dismutases (Cu2Zn2SOD), which play
important role in cellular response to oxidative stress by detoxifying the superoxide
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anion radical into the less harmful hydrogen peroxide.212,213. Depending on the redox
environment, copper can cycle between two states as reduced Cu+ and oxidized Cu2+
ions, allowing it to play its numerous physiological roles. Figure 5.8 shows dual roles
of this metal as a mediator of S-nitrosothiol (HCYSNO) formation and decomposition.
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Figure 5.8: Absorbance traces showing the effect of varying Cu2+ concentrations on
the rate of formation of HCYSNO. There is a progressive increase in the rate of
HCYSNO formation with increase in Cu2+ concentration. [HCYSH]0 = [NO2-]0 =
[H+]0 = 0.05 M; [Cu2+]0 = (a) 0.00 M, (b) 1.0 mM, (c) 2.0 mM, (d) 3.0 mM, and (e)
4.0 mM and (f) 5.0 mM.
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Trace a represents a control experimental run without copper ions. Traces b-f has the
same initial conditions as trace a but with varying amounts of Cu2+ ions. The plot
shows a progressive increase in the rate of formation of HCYSNO with increase in the
initial concentrations of Cu2+ ions. High concentrations of Cu2+ ions give an early
onset of the decomposition of HCYSNO as shown in traces e and f. This observed
effect of copper was virtually halted by the addition of excess EDTA which sequesters
copper ions.

Transnitrosation: Transnitrosation is a physiologically important reaction between Snitrosothiols (RSNO) and thiols (R'SH). It involves transfer of NO group from an Snitrosothiol to a thiol to form a new S-nitrosothiol (R5.6):

RSNO + R'SH

R'SNO + RSH

(R5.6)

In this study, S-nitrosoglutathione (GSNO) and S-nitroso-N-acetyl-D,L-penicillamine
(SNAP) were used to transnitrosate HCYSH. They were synthesized as described in
the literature.214,215 These two S-nitrosothiols have been shown to have excellent
clinical applications.216 GSNO in particular is believed to be involved in the storage
and transport of NO in mammals.97,217,218.
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Figure 5.9a: Absorbance traces showing the effect of varying HCYSH
concentrations on its transnitrosation by GSNO. The plot shows the formation of
HCYSNO at 545 nm. The increase in absorbance is due to the formation of
HCYSNO which has a higher absorptivity coefficient of 20.2 M-1 cm-1 than 17.2 M1

cm-1 of GSNO at 545 nm. [GSNO]0 = 0.003 M; [HCYSH]0 = (a) 0.0 M, (b) 0.005

M, (c) 0.01 M, (d) 0.02 M, (e) 0.03 M, and (f) 0.04 M.
Spectrophotometric studies of transnitrosation between primary S-nitrosothiols such as
HCYSNO and GSNO are generally difficult because most nitrosothiols absorb at
about the same wavelength (λmax(GSNO) = 335 nm and 544 nm; λmax(HCYSNO) = 331 nm
and 545 nm), but we were able to follow the formation of HCYSNO upon
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transnitrosation of HCYSH by GSNO because HCYSNO has a slightly higher
absorptivity coefficient (ε545nm = 20.2 M-1cm-1) than GSNO (ε545nm = 17.2 M-1cm-1)219.
Figure 9a shows the transnitrosation of HCYSH by GSNO to form HCYSNO. Trace a
is from pure GSNO without HCYSH. Traces b-f with equal amounts of GSNO show a
monotonic increase in amount and rate of formation of HCYSNO with increase in the
initial concentrations of HCYSH. Confirmatory evidence for the transnitrosation was
achieved by electrospray ionization mass spectrometry (ESI-MS) technique. Figure 9b
shows that the product of transnitrosation contains a mixture of components including
HCYSNO, GSSG (oxidized glutathione) and mixed disulfide of homocysteine and
glutathione.
Transnitrosation by SNAP is simpler and can be monitored
spectrophotometrically due to the fact that SNAP and HCYSNO absorb at different
wavelengths. Figure 5.10a shows the decomposition of SNAP at 590 nm and
simultaneous formation of HCYSNO at 545 nm. Figure 5.10b shows that the effect of
HCYSH on its transnitrosation at a constant initial concentration of SNAP is linear,
with a first order dependence.
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Figure 5.9b: A ESI-MS spectrum of a 1:5 ratio of GSNO to HCYSH. Final
products were mixture of GSH, GSSG, HCYSNO, and mixed disulfide of
GSH/HCYSH.
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Figure 5.10a: Absorbance traces showing the effect of varying HCYSH
concentrations on its transnitrosation by SNAP. The plot shows both formation of
HCYSNO at 545 nm (solid lines) and decomposition of SNAP at 590 nm (dotted
lines). [SNAP]0 = 0.0049 M; [HCYSH]0 = (a) 0.005 M, (b) 0.0075 M, (c) 0.01 M,
(d) 0.02 M, (e) 0.03 M, (f) 0.04 M and (g) 0.05 M.
The intercept (4.24 x 10-3 M) on the [HCYSH] axis corresponds to the equilibrium
concentration of HCYSH that reacts with SNAP to produce HCYSNO in agreement
with the expected 1:1 stoichiometry ratio in equation R5.6. The catalytic effect of
copper on the rate of transnitrosation was shown in Figure 5.10c. Trace a is a reaction
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mixture without Cu2+ ion. The rate of formation of HCYSNO increases with increase
in Cu2+ ion as we have in traces b-e until saturation at f.
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Figure 5.10b: Initial rate plot of the data in Figure 5.10a. The plot shows linear
dependence on initial rate of formation of HCYSNO on HCYSH in the
transnitrosation of HCYSH by SNAP.
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Figure 5.10c: Absorbance traces showing the effect of varying Cu2+ concentrations
on the rate of decomposition of of SNAP at 590 nm and simultaneous formation of
HCYSNO at 545 nm (solid lines) during transnitrosation reactions. [HCYSH]0 =
0.03 M; [SNAP]0 = 0.01 M; [Cu2+]0 = (a) 0.00 M, (b) 5 µM, (c) 10 µM, (d) 50 µM,
(e) 100 µM, (f) 500 µM, (g) 1000 µM and (h) 2000 µM.

5.2 MECHANISM
The proposed mechanism for the formation of S-nitrosohomocysteine from the
reactions of homocysteine and acidic nitrite should accommodate the involvement of
multiple nitrosating agents in the nitrosation process (Scheme 5.1).
150

+

NO+

HC
YS
H

H

H+ + NO2-

HCYSH

HNO2

HCYSNO
H
YS
C
H

HN
O

2

N2O3

Scheme 5.1: Reaction pathways, showing the involvement of multiple nitrosating
agents in the nitrosation of HCYSH to form HCYSNO by acidic nitrite.

The first step is the formation of nitrous acid (R5.7):

H+ + NO2-

HNO2

k1, k-1; Ka-1

R5.7

This is followed by the production of other nitrosating agents through the bimolecular
decomposition of HNO2 to form dinitrogen trioxide, N2O3 (R5.8), and protonation to
form nitrosonium cation, NO+ (R5.9):

2HNO2
HNO2 + H+

N2O3 + H2O
NO+ + H2O

k2, k-2

R5.8

k3, k-3

R5.9

These nitrosating agents are electrophilic and attack the highly nucleophilic sulfur
center of homocysteine to form S-nitrosohomocysteine (R5.10, R5.11 and R5.12).
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The order of increasing electrophilicity of these nitrosating agents is:220 HNO2 < N2O3
< NO+.

HCYSH + HNO2 → HCYSNO + H2O

k4

R5.10

HCYSH + N2O3 → HCYSNO + H+ + NO2- k5

R5.11

HCYSH + NO+

R5.12

HCYSNO + H+

k6, k-6

The mechanism of reaction can be explained by each of the nitrosating agents, whose
degree of involvement in the process of nitrosation significantly depends on the pH of
their environment. For example, at pH conditions around 1.3, HNO2 and NO+ are the
most relevant nitrosating agents. Protonation of HNO2 to form NO+ is favored in these
highly acidic conditions. NO+ is expected to be the more powerful nitrosating agent.
On the other hand, at less acidic pHs around 3.8, for reactions in excess nitrite as
observed in traces a-e of Figure 5.7a, HNO2 and N2O3 are the main nitrosating agents
with the rate of nitrosation by N2O3 being higher than that by HNO2 in accordance
with the electrophilic trend. The overall rate of reaction, on the basis of rate of
formation of HCYSNO, is given by:

d[HCYSNO]
dt
= k4[HCYSH][HNO2] + k5[HCYSH][N2O3] + k6[HCYSH][NO+] - k-6[HCYSNO][H+]

Rate =

Since, initially, there is no accumulation of HCYSNO at the beginning of the reaction,
the last term in equation (1) can be ignored, giving:
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(1)

d[HCYSNO]
dt
= k4[HCYSH][HNO2] + k5[HCYSH][N2O3] + k6[HCYSH][NO+]

Rate =

(2)

Equation (2) can be further simplified by applying steady state approximation on both
N2O3 and NO+ since they are transient intermediates with negligible concentrations at
any time during the reaction. They react as soon as they are produced.

[N2O3] =

[NO+] =

k2[HNO2]2
k-2 + k5[HCYSH]

(3)

k3[HNO2][H+]
k-3 + k6[HCYSH]

(4)

Substituting equations (3) and (4) into equation (2) and simplifying gives the
following rate equation:

d[HCYSNO]
dt
= [HCYSH][HNO2] k4 +

Rate =

k2k5[HCYSH][HNO2]2
k3k6[H+]
+
k-2 + k5[HCYSH]
k-3 + k6[HCYSH]

(5)

where:
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+
[HNO2] = [N(III)]T[H+ ]
Ka + [H ]

(6)

where [N(III)]T from mass balance equation for the total N(III) containing species is:

[N(III)]T = [NO2-] + [HNO2] + [HCYSNO] + [N2O3] + [NO+]

(7)

HCYSH is the sum of the protonated and unprotonated HCYSH.
The proposed rate equation is valid from low to slightly acidic pH. At low pH
conditions, for reactions run in excess acid, the bimolecular decomposition of HNO2
to form N2O3 becomes irrelevant and the last term in equation (5) can be ignored,
resulting in first-order kinetics in nitrous acid with a rate equation given by:

d[HCYSNO]
dt
= [HCYSH][HNO2] k4 +

Rate =

k3k6[H+]
k-3 + k6[HCYSH]

(8)

Rate equation (8) is supported by the kinetics data shown in Figures 5.6a, 5.6b, 5.7a
and 5.7b. On the other hand, for reactions in excess nitrite, when the final perchloric
acid concentrations tend to zero, second-order kinetics, which fitted well into a
polynomial of degree two were observed. By ignoring the term containing [H+] in
equation (5) we will obtain a rate equation (9):
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d[HCYSNO]
dt
k k [HCYSH][HNO2]2
= k4[HCYSH][HNO2] + 2 5
k-2 + k5[HCYSH]

Rate =

(9)

Equation (9) is supported by the kinetics data shown in Figures 5.6a, 5.6c, 5.6d, 5.7c
and 5.7d.
As shown in equations 8 and 9, there are five kinetics constants to be evaluated.
Equilibrium constants K2 = 3.0 x 10-3 M-1 and K3 = 1.2 x 10-8 M-1 as well as the rate
constant k-2 = 5.30 x 102 s-1 have already been established.26,221,222 The data in Figures
5.7a-d provide rate constants for direct reaction of HCYSH and HNO2 of 9.00 x 10-2
M-1s-1, HCYSH and N2O3 of 9.49 x 103 M-1s-1 and HCYSH and NO+ of 6.57 x 1010 M1 -1

s . These values agree with the order of electrophilicity of these three nitrosating

agents (HNO2 < N2O3 < NO+).

5.3 COMPUTER SIMULATIONS
A network of eight reactions as shown in Table 5.2 can adequately model entire
nitrosation reactions. Kintecus simulation software developed by James Ianni was
used for the modeling.223 The rate constant for the formation of nitrosating agents
(HNO2, N2O3 and NO+, Reactions M1 – M4) were taken from literature values.26,221,222
The forward and reverse rate constants used for M2 and M3 fit well for the modeling
and agreed with the literature values for the equilibrium constants 3.0x10-3 M-1 and
1.2x10-8 M-1 for reactions R5.8 and R5.9 respectively. Experimental data for reactions
in highly acidic pH 1.2 (Figure 5.7a) and mildly acidic pH 4.0 (Figure 5.7c) were
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simulated using the bimolecular rate constants, k4, k5 and k6 determined according to
our proposed mechanism. In highly acidic pH the simulations were mostly sensitive to
the values of rate constants kM1, kM2 and kM6. The rate of acid catalysed decomposition
of HCYSNO was found to be halved as the initial concentrations of nitrous acid
doubled. Reactions M1, M3, M4, M7 and M8 are the most relevant reactions in mildly
acid pH. Figures 5.11a and 5.11b show a comparison between the experimental results
(traces a and b in Figures 5.7a and 5.7c) and our simulations. Reseasonably good fits
were obtained and the simulations were able to reproduce the formation of HCYSNO
in high to mild acidic pHs by the reaction of homocysteine and the nitrosating agents.

Table 5.2: Mechanism used for simulating the S-nitrosation of homocysteine. RSH
stands for homocysteine.
Reaction
No.
M1

Reaction
H+ + NO2-

kf; kr
HNO2

1.10 x 109 M-1s-1; 6.18 x 105 s-1
(Ka(HNO2) = 5.62 x 10-4)

M2

HNO2 + H+

+

N=O + H2O

4.00 x 101 M-1s-1; 3.33 x 109 s-1
(KM3 = 1.2 x 10-8 M-1)

M3

2HNO2

N2O3 + H2O

1.59 ± 0.50 M-1s-1; 5.30 x 102 s-1
(KM2 = 3.0 x 10-3 M-1)

M4

N2O3

NO + NO2

M5

RSH + HNO2 → RSNO + H2O

M6

RSH + +N=O

M7

RSH + N2O3 → RSNO + HNO2

M8

2RSNO

RSNO + H+
RSSR + 2NO

8.0 x 104 s-1; 1.1 x 109 M-1s-1
9.0 x 10-2 M-1s-1; ca. 0
6.57 x 1010 M-1s-1; 3.6 x 103 M-1s-1
9.49 x 103 M-1s-1; ca. 0
5.0 x 10-2 M-1s-1; ca. 0
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Figure 5.11a: Comparison of experimental (solid lines, traces a and b from Figure
5.7a) and computer simulations (dotted lines) using the mechanism shown in Table
2 for the formation of HCYSNO in highly acidic environment (pH 1.2). [HCYSH] =
5.00 x 10-2 M; [HNO2] = (a) 5.00 x 10-3 M and (b) 1.00 x 10-2 M.
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Figure 5.11b: Comparison of experimental (solid lines, traces a and b from Figure
5.7c) and computer simulations (dotted lines) using the mechanism shown in Table
5.2 for the formation of HCYSNO in mildly acidic environment (pH 4.0). [HCYSH]
= 5.00 x 10-2 M; [HNO2] = (a) 5.00 x 10-3 M and (b) 1.00 x 10-2 M.

5.4 CONCLUSION
This study has shown that the conversion of HCYSH to the highly toxic homocysteine
thiolactone can be prevented by the inhibition of the sulfur center of HCYSH by Snitrosation. Nitrosation by dinitrogen trioxide and transnitrosation by other S158

nitrosothiols such as S-nitrosoglutathione (GSNO) are the most effective mean of Snitrosation in mildly acid pHs to physiological pH 7.4. The high stability of HCYSNO
at physiological pH, which rival GSNO, is an advantage in the modulation of HCYSH
toxicities by S-nitrosation.
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CHAPTER 6
SUMMARY, CONCLUSIONS AND FUTURE PERSPECTIVES
6.0 SUMMARY
The research profile in this dissertation has shown that S-nitrosothiols, Snitrosocysteamine (CANO), S-nitrosocysteine (CYSNO) and S-nitrosohomocysteine
(HCYSNO), can be produced by the reaction of acidic nitrite and corresponding parent
aminothiols. These S-nitrosothiols can also be formed by transnitrosation by other Snitrosothiols at physiological pH 7.4. Formation of these RSNOs is consistent with
evidence in literature supporting formation of RSNO by reaction of thiols and
nitrosating agents.82,106,137 Their kinetics and mechanisms of formation and
decomposition were elucidated. The S-nitrosothiols studied are primary nitrosothiols
with characteristic pink color and absorbance in the UV/vis in the 333 – 335 nm and
544-545 nm regions (see Table 6.1).

Table 6.1: Absorbance maxima and extinction coefficients for the S-nitrosothiols
S-nitrosothiols

S-nitrosocysteine

Color

UV/Vis

Molar Extinction

Absorption

Coefficients

Maxima (nm)

(M-1cm-1)

Pink

544

17.2

Pink

545

20.2

Pink

545

16.0

(CYSNO)
S-nitrosohomocysteine
(HCYSNO)
S-nitroscysteamine
(CANO)
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Five nitrosating agents were identified in the reaction of nitrite and acid
(Scheme 6.1). They are NO, NO2, N2O3, NO+ and HNO2. The particular nitrosating
agent that will be involved in the process of nitrosation was found to be dependent on
pH of medium. The proposed mechanism in this thesis has shown that, in highly acidic
environments, HNO2 and NO+ are the main nitrosating agents and in mild to
physiological pHs, N2O3 and HNO2 are the most relevant nitrosating agents. NO and
NO2 are radicals and hence can function as effective nitrosating agents either by a
direct reaction with thyl radicals or by an indirect reaction with thiols via the
formation of a new nitrosating agent N2O3 in an aerobic environments (R6.1 and
R6.2).

2NO + O2 → 2NO2

R6.1

NO + NO2 → N2O3

R6.2

Under acidosis or acidic conditions of the stomach, nitrite is rapidly protonated to
form HNO2 which can then decompose to NO and NO2.224,225 HNO2 can also react
with excess acid to produce NO+.226

Kinetics of RSNO formation: Results from this study have shown that a slight change
in substitution at the β-carbon of aminothiols has a great impact on their reaction
dynamics. Electron density around S-center plays a significant role in the reactivities
of the parent thiols. An electron-donating group increases the electron density on S161

center of the parent thiol as well as the corresponding RSNO. In this study,
cysteamine, with the most nucleophilic S-center of the three aminothiols (cysteamine,
cysteine and homocysteine), has the highest rate of nitrosation. The order of the rate of
formation of the three RSNOs at pH 1.2 is CYSNO < HCYSNO < CANO (see Figure
6.1 and Table 6.2).

RSH

Scheme 6.1: Reaction scheme for the nitrosation of thiols
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Figure 6.1: Comparison of rate of formation of HCYSNO, CYSNO and CANO at
pH 1.2.
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Table 6.2: Correlation of first-order rate constant of the S-nitrosothiols with pKa of
the aminothiols.
S-nitrosothiols

Structure

pKa

kobs (s-1)

8.30

1.12

10.00

2.54

10.75

3.19

SNO

S-nitrosocysteine
(CYSNO)

NH2
O
OH

SNO

Snitrosohomocysteine
(HCYSNO)

OH
NH2
O
SNO

S-nitroscysteamine
(CANO)
NH2

The result, as presented in Figure 6.2, shows that acid dissociation constants (pKa
values) of the –SH group of the parent thiols strongly influence the rate of formation
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of S-nitrosothiol. The rate of formation increases linearly with increase in the pKa
values of the thiol. This observed linear correlation between pKa values and rates of
formation of S-nitrosothiol is due to the increase in nucleophilicity with increase in
pKa values.227 This indicates that the higher the pKa value, the higher the electron
density around S-center and the faster the rate of S-nitrosation of primary aminothiols.

3.5

NO
CA
3.0

YS
C
H

kobs/s-1

2.5

NO

2.0

1.5

S
CY

1.0
8.0

NO
8.5

9.0

9.5

10.0

10.5

11.0

pKa
Figure 6.2: Linear dependence of Pseudo first-order rate constants, kobs on the pKa
of sulfhydryl group of the parent aminothiols of (a) HCYSNO, (b) CYSNO and
CANO.
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Equation 6.1 shows a generalized rate equation that can be applied to the S-nitrosation
of aminothiol by acidic nitrite at low to mildly acidic pHs.

d[RSNO]
dt
= [RSH][HNO2] k4 +

Rate =

k2k5[RSH][HNO2]2
k3k6[H+]
+
k-2 + k5[RSH]
k-3 + k6[RSH]

(6.1)

k2, k3, k4, k5 and k6 are rate constants for the following equations:

H+ + NO2-

k1, k-1; Ka-1

R6.3

k2, k-2

R6.4

k3, k-3

R6.5

RSH + HNO2 → RSNO + H2O

k4

R6.6

RSH + N2O3 → RSNO + H+ + NO2-

k5

R6.7

RSH + NO+

k6, k-6

R6.8

2HNO2
HNO2 + H+

HNO2
N2O3 + H2O
NO+ + H2O

RSNO + H+

At low pH conditions, reactions R6.3, R6.5 and R6.8 predominate and the terms with
k2, k-2 and k5 in equation 6.1 becomes negligible, resulting in first order kinetics in
nitrous acid with a rate equation given by:

d[RSNO]
dt
= [RSH][HNO2] k4 +

Rate =

k3k6[H+]
k-3 + k6[RSH]

(6.2)
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In mildly acidic pHs, when reactions R6.3, R6.6 and R6.7 become the most relevant,
equation 6.1 predicts second order kinetics with respect to nitrous acid, with a rate
equation given by equation 6.3.

d[RSNO]
dt
2
= k4[RSH][HNO2] + k2k5[RSH][HNO2]
k-2 + k5[RSH]

Rate =

(6.3)

Transnitrosation: Transnitrosation involves a direct transfer of the NO group from one
thiol to another without the release of NO. It has been shown to proceed by an attack
of a nucleophilic thiolate anion on an electrophilic S-nitrosothiol through a nitroxyl
disulfide intermediate (Scheme 6.2)228-230.

O

RS-N=O + R'S-

R

R'

N
S

RS'NO + RS-

S

Scheme 6.2: Transnitrosation reaction mechanism

The reaction is first-order in both thiol (R’SH) and S-nitrosothiol (RSNO). The results
as presented in Figure 6.3 for the transnitrosation of cyseine, homocysteine and
cysteamine by SNAP were found to be related to the dissociation constant of the
sulfhydryl group of these thiols. The higher the pKa the faster the rate of
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transnitrosation, which means that rate-determining step for this reaction is the
nucleophilic attack of thiolate anion on the nitrogen atom of the nitroso group of
SNAP. Plot of the measured first-order rate constant, kobs versus pKa was linear
(Figure 6.4). The intercept on the pKa axis of 7.57 is very significant as it seems to be
the minimum pKa of aminothiol that can be transnitrosated by SNAP. One can infer
that any aminithiol with pKa less than the physiological pH of 7.4 cannot be
transnitrosated by SNAP.
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Figure 6.3: Comparison of transnitrosation of HCYSNO, CYSNO and CANO.
Rate of transnitrosation increases with increase in pKa of the parent aminothiols
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Figure 6.4: Correlation of first-order rate constants of transnitrosation of the
aminothiols with pKa. Rate of transnitrosation increases with increase in pKa of the
parent aminothiols

Stability: The stability of RSNO is crucial to its expected roles as the carrier, transport
form and reservoir for NO bioactivity in the physiological environments. The S—NO
bond stability is believed to be modulated by the structure of the specific RSNO.231
For example, in this study the lengthening of the alkyl chain as in HCYSNO was
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found to enhance its stability when compared with CYSNO and CANO (Figure 6.5).
This suggests lengthening of the alkyl chain strengthens the S—N bond. Dissociation
energies for the S—N bond for cysteine and homocysteine have been previously
determined by Toubin et al as 29.5 and 35.8 kcal/mol respectively.191
In this thesis, copper ions were found to catalyse the decomposition of RSNO.
The rate of decomposition increases with increase in copper concentrations. Figure 6.5
shows a comparison of the rate of Cu (II) ion catalyzed decomposition of the three
RSNOs, CANO, CYSNO and HCYSNO.
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HCYSNO
0
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[Cu(II)]/M

Figure 6.5: Effect of Copper(II) on the stability of HCYSNO, CANO and CYSNO.
HCYSNO was the most stable of the three RSNOs.
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The intercepts on the initial rate-axis are very significant as they give the initial rate of
decomposition of the RSNOs in the absence of the metal ions. The fact that HCYSNO
intercept is kinetically indistinguishable from zero is an indication that HCYSNO is
relatively stable at physiological pH 7.4. The order of stability is CYSNO < CANO <
HCYSNO. Table 6.3 shows the half-lives of these RSNOs at physiological pH 7.4 in
the presence of metal ion chelator (EDTA) and in the presence of copper (II) ions
without metal ion chelator. CYSNO has the shortest half-life of 0.5 s in the presence
of copper. A half-life of 2.0 s has been previously reported for CYSNO in plasma.232
The rapid metabolism of CYSNO and CANO to release NO may make these
compounds advantageous as vasodilators in medical applications.

Table 6.3: Half-lives of the RSNOs in the presence and absence of metal ions
Half-life, t1/2 (s)
RSNO
CYSNO

Presence of EDTA as

Presence of

metal ion chelator

Copper (II) ions

3.58 x 104

0.50

(or 10.00 hrs)
CANO

1.10 x 105

0.84

(or 30 hrs)
HCYSNO

7.13 x 105

16.5

(198 hrs)
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The general instability of RSNOs in the presence of copper ions is due to the
lengthening of the S—N bond and shortening of N—O bond as observed in the
copper-RSNOs intermediate complex, [RS(Cu)NO]+ (equation R6.9). For example
S—N bond lengths of S-nitrosocyteine are 1.87 Å and 2.11 Å in the absence and
presence of copper ions respectively.191 The corresponding N—O bond lengths from
quantum mechanical studies are 1.18 Å and 1.14 Å in the absence and presence of
copper ions respectively.191

Cu+ + RSNO → [RS(Cu)NO]+ → RS- + NO + Cu2+

R6.9

6.1 CONCLUSIONS AND FUTURE PERSPECTIVES
This study has shown that the rate of S-nitrosation and transnitrosation of
thiols to form S-nitrosothiols and subsequent decomposition of S-nitosothiols to
release nitric oxide depend on a number of factors which include the dissociation
constant (pKa) of the sulfuryl group, pH of their environments, nature of substitution
at β-carbon, length of the alkyl chain and copper ion concentrations. The larger the
pKa of the sulfuryl group of the thiol the faster the rate of nitrosation by acidic nitrite
and transnitrosation by other S-nitrosothiols. Also the longer the length of the carbon
chain the higher the stability. The stability of S-nitrosohomocysteine even in the
presence of metal ions at physiological pH is particularly intriguing, since it is very
important in the modulation of homocysteine related diseases. This dissertation has
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thus revealed new therapeutics way for hyperhomocysteinemia, which is a risk factor
for many diseases such as cardiovascular and neurodegenerative diseases, through Snitrosation of homocysteine.
Results from this study have shown that RSNOs can be used as NO donors.
They can be utilized in the development of NO-releasing compounds for various
biomedical applications. For example, NO has been demonstrated as a facilitator of
wound healing for people with diabetes.233-235 The only factor that may limit their
biomedical applicability is their rapid decomposition rates at physiological pH 7.4,
especially in the presence of metal ions as observed in this study. In order to overcome
this deficiency, there is a need for modification of the structure of RSNOs in a way
that prolongs their stability. This can be achieved by developing hydrophobic
macromolecules in which RSNO will be covalently incorporated into the polymer
backbone. Results from this dissertation will serve as a base for the design of such
polymers. Also, catalytic effect of copper, as observed in this study, in stimulating the
formation of RSNO and its subsequent decomposition to release NO can be an
advantage in the development of biomedical devices where continuous generation of
NO is desirable. This can offer a potential solution to the blood-clotting problems
often encountered in blood-containing medical devices,236 since NO is an excellent
inhibitor of blood platelets aggregation.7 Too many platelets can cause blood
clotting,237 which may obstruct the flow of blood to tissues and organs (ischemia),
resulting in stroke and/or heart attack. Bioactive polymer such as poly vinyl chloride
(PVC), polyurethane (PU) and polymethacrylate doped with copper (II) ligand sites
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can therefore be used as blood platelets aggregation resistant materials. The copper (II)
sites within the polymer can catalyze nitrosation of thiols by nitrite and reduced to
copper(I). The copper (I) sites in the polymer can then catalyze decomposition of
RSNO to NO and thiolate anion. Provided that the blood contacting the polymer has
some level of naturally occurring thiols like cysteine and cysteamine, and nitrite at all
time, generation of NO at the blood-polymer interface should continue in a cycling
manner as presented in Scheme 6.3.

Cu2+

Cu2+
Cu+
T

l
hio

re d

e
tas
uc

RSH + NO2-

NO + RSSR

Cu

Cu+

RSNO
Cu+

+

Cu2+

RS- + NO

Cu2+

Scheme 6.3: Redox cycling copper catalyzes continous generation of NO from the
reaction of nitrite and bioactive thiols. Using copper (II) doped polymer for coating
biomedical devices will enhances continuous production of NO.
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